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ABSTRACT 
 
Fibroblasts are the most abundant cell type of the stroma, producing extracellular matrix 
components which provide mechanical strength to tissues. Recent work has shown that 
fibroblasts are not simply passive structural cells but active participants in the immune response. 
Work on human fibroblasts has demonstrated distinct gene expression profiles dependent on 
their tissue of origin, indicating that fibroblasts impart topographical memory and positional 
identity to tissues.  
 
In this study fibroblast heterogeneity within the murine lymphoid system was investigated by 
analysing gene and protein expression. Their functional ability to form lymphoid like structures 
was also assessed.  Fibroblasts were isolated from a range of lymphoid and peripheral sites. Our 
findings show that fibroblasts grown from different sites show heterogeneous gene and protein 
expression and are also functionally different in their response to lymphotoxin α treatment in 
vitro and in their capacity to recruit host leucocytes in vivo. A novel in vivo functional assay has 
been developed using a collagen sponge as a three-dimensional structure in the kidney capsule 
transfer model, to assess the ability of fibroblasts to form and maintain lymphoid structures. 
 
We conclude that murine fibroblasts isolated from lymphoid tissues, display site specific 
features. They are phenotypically distinct with site specific gene and protein expression profiles. 
These differences are reflected in functionally unique interactions with leucocytes and their cell 
products. This suggests that murine lymphoid fibroblasts have positional memory and help 
impart anatomical identity. An important implication of these findings is the effect this diversity 
may have in conveying site specificity to immune responses. Our work supports the hypothesis 
that fibroblasts help define a stromal postcode that directs leucocyte behaviour within lymphoid 
tissues.  
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Chapter One 
Introduction
Chapter One Introduction 2 
CHAPTER ONE 
Introduction 
 
1.1 The Immune System 
Pathogens are encountered routinely, but only rarely cause disease. Pathogens first 
face anatomic barriers such as skin and mucous membranes and physiologic barriers 
such as temperature, the low pH of the stomach and lysozyme in tears. Should a 
pathogen get past these barriers the human immune system has various methods of 
recognising and responding to invasion by non-self (1). 
 
The immune system comprises many cell types which differentiate from a pluripotent 
haematopoietic stem cell (figure 1.1). These cells mediate an immune response which 
consists of two branches; the innate and adaptive systems. Innate immunity is driven 
by an antigen-non-specific mechanism which a host uses immediately or within 
several hours after exposure to an antigen. This is the initial response by the host to 
eradicate microbes and prevent infection. However, although it can distinguish self 
from non-self, it offers no memory or lasting protective immunity. Adaptive 
immunity is driven by an antigen-specific mechanism that takes several days to 
become protective. It is designed to react with and remove a specific antigen and 
continues to develop throughout life, providing memory against re-infection (2).
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Figure 1.1 Cell lineage in the immune system 
All cells arise from pluripotent haematopoietic stem cells in the bone marrow. 
Initially these give rise to stem cells of a more limited potential which differentiate 
into the many cell lineages [Taken from Janeway et al, 2005 (1)]. 
 
 
1.1.1 Innate Immunity 
The cells of the innate immune system include phagocytes such as macrophages, 
neutrophils and immature dendritic cells (DCs), which engulf and kill invading 
pathogens by phagocytosis. This involves surrounding the pathogen with a phagocyte 
membrane and then internalising it in a membrane-bound vesicle termed a 
phagasome. This becomes acidified, killing most pathogens. Macrophages and 
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neutrophils also contain lysosomes which are membrane bound granules containing 
enzymes, proteins and peptides. The phagosome fuses with one or more lysosomes to 
form a phagolysosome, in which the lysosomal contents are released to destroy the 
pathogen (3). Neutrophils are short lived cells and die after completing phagocytosis, 
they are the most abundant leucocyte population, representing about 60% of all 
circulating leucocytes (4). In comparison macrophage cells are long lived and after 
phagocytosis continue to produce new lysosomes (3). Immature DCs, phagocytose 
pathogens and present their degraded proteins using major histocompatablity complex 
(MHC) proteins whilst simultaneously upregulating co-receptors for T cell activation 
such as CD80 and CD86 and also CCR7 which encourages the DC to travel to the 
spleen or a lymph node. Here they function as an antigen presenting cell (APC) and 
can induce an adaptive immune response. The DCs enter the lymph nodes as mature 
non-phagocytic cells which can activate antigen-specific thymus derived (T) cells (5). 
In addition, granulocytes such as mast cells, eosinophils and basophils release 
cytokines that cause dilation of blood vessels and increased vascular permeability. 
These cells are thought to be involved in allergic responses and defence against 
parasites (3).  
As well as the cellular component of the innate immune system which acts mainly in 
the tissues, the complement system is an enzyme system activated in the blood. There 
are three pathways leading to complement activation: the classical pathway, the 
mannose binding (MB) lectin pathway and the alternative pathway (6). The classical 
pathway is activated by IgG or IgM antibody molecules produced by bone marrow 
derived (B) cells and is part of the adaptive immune response (7). The MB lectin 
pathway is activated by mannose and fructose residues on bacterial cell walls, and the 
alternative pathway by spontaneous hydrolysis of C3 from plasma to the surface of a 
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pathogen, both of which are innate mechanisms (8). The pathways all lead to the 
activation of C3, which is the central component of the cascade. The larger fragment 
of C3, C3b, binds to the surface of the pathogen present and activates the complement 
cascade which ultimately results in the formation of membrane attack complexes. 
These insert into the pathogen cell membrane, form a transmembrane pore and cause 
lysis of the bacterium (1). 
A third system utilised by the innate immune system is recognition of common 
pathogen associated components, named pathogen-associated molecular patterns 
(PAMPs). These are usually components of a pathogen that they cannot survive 
without or cannot easily mutate without affecting their capacity to cause infection (9). 
The innate immune system relies on a set of germline encoded receptors called 
pattern-recognition receptors (PRRs) to recognise these PAMPs. Examples of these 
PRRs include Toll-like receptors (TLRs) of which over ten have been identified in 
humans that recognise different PAMPs. Examples of PAMPs include 
lipopolysaccharide (LPS) and peptidoglycan recognised by TLR4 and 2 respectively 
(10). The role of the TLRs is then to activate phagocytes and DCs to respond to the 
pathogens by secreting chemokines and cytokines, and to induce DC maturation (11). 
The key to the innate response is its rapid onset with the peak response being just a 
few hours after infection. Without this, many infections would prove lethal while 
waiting for the body to mount an adaptive response. The innate response subsides 
either as an infection is resolved or as the adaptive response comes into play (12). 
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1.1.2 Adaptive Immunity 
Many pathogens can evade the initial non-specific response, this is when the adaptive 
arm of the immune response comes into play. This is a specific response to a pathogen 
and occurs over a period of several days from when a pathogen is first encountered. 
The adaptive immune response requires T and B lymphocytes that recognise specific 
antigens presented on the surface of APCs. Both T and B lymphocytes originate in the 
bone marrow, but only the B lymphocytes mature there. T lymphocytes migrate to the 
thymus and it is here they undergo maturation and selection. Once maturation is 
completed both cell types enter the bloodstream, from which they traffick to lymph 
and peripheral lymphoid organs continuously. It is in the peripheral lymphoid organs 
where antigen and lymphocytes will eventually meet, triggering the adaptive immune 
response (1).  
 
1.1.2.1 Lymphocytes 
Lymphocytes account for 20-40% of all white cells in the circulating blood. Early in 
lymphocyte development their receptor genes undergo rearrangement so that each 
receptor is structurally diverse. There are approximately 10
11
 different lymphocytes in 
the human body, each with the ability to bind different antigen (1,2).  
 
B cells produce antibodies which interact with pathogens and their toxic products in 
the extracellular spaces of the body. The immunoglobulin receptors of the B cell 
recognise antigen in its unprocessed state, the antigen-recognition molecules produced 
are made both as membrane bound receptors and as secreted antibodies. The majority 
of B cell responses, though, depend on the interaction with specialised T cells, in 
lymphoid tissues, for the generation of efficient high affinity antibody responses (6). 
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In contrast, T cells are specialised for cell-cell interaction. Antigen presented to T 
cells must be displayed bound to MHC proteins on the surface of the body‟s own 
cells. There are two main types of T cells, helper T cells which express CD4 and 
cytotoxic T cells which express CD8. CD4
+
 T cells generally interact with peptide 
antigens bound to MHC class II proteins (13). These peptides are generated from 
exogenous antigens taken up by APCs, which process the antigen intracellularly and 
present the resulting peptides on MHC class II proteins in combination with co-
stimulatory molecules such as CD80 and CD86 to CD4
+
 T cells. APCs include DCs 
and macrophages, however only DCs are thought to be able to activate or “prime” 
naïve, not previously activated T cells (14). CD4 expressing T cells are split into two 
further subsets; Th1 cells which are important in intracellular bacterial infections and 
Th2 cells which are involved in stimulating B cells, mast cells and eosinophils and are 
important in parasite infections (15). More recently a new population of CD4
+
 T cells 
has become apparent; these are CD4
+
CD25
+
 and have been named regulatory T cells 
(Tregs). The Tregs make up approximately 5-10% of the lymphocyte population and 
they can inhibit activation of effector T cells by secreting inhibitory cytokines, such as 
IL-10, which prevents IL-2 production (16). The peptides activating the Treg receptor 
tend to be self peptides and so it is thought they have a role in the prevention of 
autoimmune responses (17). Cytotoxic CD8
+
 T cells recognise their antigen in 
conjunction with MHC class I proteins (18). MHC class I is expressed by most 
nucleated cells. MHC class I proteins generally present peptides derived from proteins 
produced within the presenting cell. CD8
+
 effector T cell antigens recognise cells 
infected with virus or other intracellular pathogens and kill directly by inducing 
apoptosis of the infected cell. Some CD8
+
 T cells require CD4
+
 T cell help to become 
activated, it is thought that the presence of the CD4
+
 T cell compensates for the 
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inadequate co-stimulation of the naïve CD8
+
 T cell. The CD4
+
 T cell induces the APC 
to increase co-stimulatory activity and thus activates the CD8
+ 
T cell (19). 
 
All T cell subsets develop in the thymus, however, only 3% become mature naïve T 
cells (20). These naïve T cells constantly recirculate between secondary lymphoid 
organs, blood and lymphatic systems. Once primed following interaction with an 
antigen experienced DC, the activated T cells down-regulate L-selectin and increase 
very late antigen-4 (VLA-4) expression on their cell surface. This change in 
phenotype results in the loss of lymph node homing, so that they are more likely to 
enter inflamed or infection sites in response to signals from innate cells such as 
macrophages (21). Importantly, for the adaptive response, while the vast majority of T 
cells die by apoptosis as the response resolves, a small subset remain after resolution 
of an infection. These memory T cells can rapidly mobilise and proliferate should the 
same antigen be re-encountered. Compared to naïve T cells, memory T cells can be 
activated by macrophages and generate a faster and more effective response at lower 
doses of antigen (22). 
 
1.1.2.2 Lymphocyte homing and trafficking 
Lymphocytes continuously re-circulate through the blood, lymphatic system and non- 
lymphoid tissue to ensure continuous surveillance for foreign antigen. It takes 
approximately 24 hours for a T cell to complete one round of migration through all 
the body‟s lymph nodes (23). Their homing and extravasation across endothelium is 
an important process as it is in the peripheral lymphoid organs where antigen and 
lymphocytes will eventually meet, triggering the adaptive immune response. The site 
where a lymphocyte extravasates is determined by the active cell surface receptor on 
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the lymphocyte interacting with its corresponding ligand on the endothelial cell. Many 
endothelial adhesion molecules are upregulated under inflammatory conditions. 
Transendothelial migration takes place in four stages: lymphocyte rolling, activation 
of integrins, tight adhesion and diapedesis (figure 1.2). 
 
 
Figure 1.2 Transendothelial migration 
Neutrophil recruitment, lymphocyte recirculation and monocyte trafficking all require 
adhesion and transmigration through blood-vessel walls. The traditional three steps of 
rolling, activation and firm adhesion, have recently been augmented and refined. Slow 
rolling, adhesion strengthening, intraluminal crawling and paracellular and 
transcellular migration are now recognized as separate, additional steps. [Taken from 
Ley et al, 2007 (24)]. 
 
Lymphocyte rolling is a reversible attachment of the cell to the endothelium; this 
slows down the cell in the bloodstream so that it may detect signals from the 
endothelium. L-selectin is expressed by most lymphocytes, this binds to receptors 
such as glycosylation-dependent cell adhesion molecule-1 (GlyCAM-1), CD34 and 
mucosal addressin cell adhesion molecule (MAdCAM) on the endothelium in the 
rolling process (25). Next the lymphocyte is activated by chemokines produced by the 
endothelial cells, this leads to increased integrin expression on the lymphocyte and the 
cells arrest.  Tight adhesion of the lymphocyte to the endothelial cell is then induced 
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by members of the immunoglobulin superfamily present on the endothelial cell 
surface binding to these integrins (26). The lymphocyte then induces the opening of 
the junction between two endothelial cells by disrupting cell-cell interactions. This 
step is believed to involve an immunoglobulin type molecule called 
platelet/endothelial cell adhesion molecule one (PECAM-1) or CD31; enabling the 
lymphocyte to „crawl‟ along the cell to the basement membrane (24). Finally the 
lymphocyte secretes enzymes to breakdown the basement membrane and enter the 
subendothelial tissue (24-26).  
 
1.2 The Lymphoid System 
The specialised structure in the human body for the distribution of immune cells is the 
lymphoid system. The lymphoid system consists of primary lymphoid organs, 
secondary lymphoid organs, and lymphatic vessels (figure 1.3). Primary lymphoid 
organs such as the bone marrow and the thymus are where the B and T cells 
respectively mature (1). After maturation, both B cells and T cells circulate through 
and accumulate in secondary lymphoid organs. Secondary lymphoid organs consist of 
the highly organised lymph nodes and spleen as well as the less organised appendix, 
Peyer‟s patches and tonsils. Secondary lymphoid organs are the predominant site of 
lymphoid sensitisation to novel antigens (27). The lymphatic vasculature forms a 
secondary circulatory system which connects the blood and lymphoid organs (28). 
Blood plasma constantly leaks out of the capillaries to deliver oxygen and nutrients to 
the tissues. Whilst most of the fluid re-enters capillaries and is returned to the 
bloodstream, some enters the lymph vessels. This lymph fluid flows through regional 
lymph nodes and eventually enters the circulatory system at the heart to maintain the 
fluid volume of the circulation (1,27). 
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Figure 1.3 The human lymphoid system 
Lymphocytes arise from stem cells in the bone marrow and differentiate in the 
primary lymphoid organs (yellow). They then migrate to secondary lymphoid organs 
(blue) and recirculate between these and the blood until they encounter their specific 
antigen. [Taken from Janeway et al, 2005 (1)].  
 
1.2.1 Lymph node development 
Development of secondary lymphoid tissue has primarily been investigated in the 
murine system. Lymph node development begins during embryogenesis and is 
thought to continue several weeks after birth (29). The precise signals that induce 
lymph node development has yet to be established, however Sabin hypothesised in 
1902 that lymphatic vessels arise by sprouting from venous endothelial cells after an 
appropriate signal (30). More recent work in mice has shown the earliest lymph sacs 
to develop at embryonic day (E) 10.5 and that the homeobox gene Prox1 is essential 
for the normal development of the lymphatic system. In Prox1 null mice initial 
budding from the veins occurred but could not be maintained causing arrest of the 
lymphatic development. However, the loss of Prox1 did not affect vascular 
development suggesting it is specifically required for the development of the 
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lymphatic system (31). As the lymph sacs are forming, mesenchymal cells 
differentiate into specialised cells that initiate the formation of lymph nodes. This 
differentiation requires the presence of growth factors such as platelet-derived growth 
factor (PDGF) (32), fibroblast growth factors (FGF) (33) and transforming growth 
factor (TGF)-β superfamily (34).  After development the lymph sac is colonised by 
lymphoid tissue inducer cells (LTi), which are haematopoietic cells that express the 
IL-7Rα chain and CD4 but lack CD3 (figure 1.4, left panel). LTi cells were first 
discovered by Kelly and Scollay in 1992. These bone marrow-derived cells form 
small clusters with resident stromal organiser cells, which express vascular cell 
adhesion molecule-1 (VCAM-1), inter-cellular adhesion molecule-1 (ICAM-1) and 
lymphotoxin β receptor (LTβR) (figure 4, right panel). This interaction is believed to 
initiate the maturation of the lymph node. The cross talk between these two cell types 
has been shown to be critical to lymph node organogenesis (35) and involves the 
ligands and receptors of the tumour necrosis family (TNF) (36). Lymphotoxin (LT) α, 
LTβ and TNF are structurally homologous cytokines grouped within the TNF ligand 
family (37). TNF and LTα can bind to TNF receptors TNFRI and TNFRII. However, 
LTβ forms a functional heterotrimeric complex, LTα1β2 to bind to its receptor, LTβR 
(38,39). 
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Figure 1.4 Requirements for the generation of functional lymphoid tissue 
inducers and organisers 
Within the lymph node anlagen, LTi cells, expressing the markers shown (left panel), 
trigger the LTβR on the lymphoid tissue organiser cells. This upregulates the 
expression of the markers shown on the organiser cell (right panel), which in turn 
mediates the clustering of the LTi cells [Taken from Cupedo et al, 2005, (35)]. 
 
1.2.1.1 Lymphotoxin signalling 
Studies have shown that LTα and LTβ have essential, non-redundant functions in 
lymphoid organ development. Mice deficient in LTα have a phenotype which consists 
mainly of defects in the secondary lymphoid system, with the absence of all lymph 
nodes and Peyer‟s patches, and the architecture of the spleen and nasal associated 
lymphoid tissue (NALT) being highly disorganised (40). This phenotype can be 
partially restored with transgenic expression of LTα under the rat insulin promoter, 
although it did not restore Peyer's patches or splenic architecture. The ability of the 
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spleen to form germinal centres and follicular dendritic cell (FDC) networks was 
however restored (41). LTβ knockout (KO) mice lack all peripheral lymph nodes and 
Peyer‟s patches but retain mucosal, cervical and sacral lymph nodes. The defects seen 
in the spleen and NALTs are decreased compared with the LTα KO mice (36,42-44). 
It has been reasoned that mesenteric and cervical lymph node formation in the LTβ 
KO mice, when other lymph nodes do not form, is due to the differential expression 
of LTβR by the corresponding stromal cells. Signalling through this receptor initiates 
a cascade of events during lymph node formation which may not be present in other 
lymph nodes (45) (section 1.2.1.3). LTβR KO mice lack all lymph nodes, Peyer‟s 
patches and colon-associated lymphoid tissue. The architecture of the spleen, 
germinal centre formation, FDC networks and immunoglobulin responses are also 
impaired. Interestingly the LTβR KO mice exhibit distinct defects not seen in the LTα 
or LTβ KOs, which suggests that the LTβR also integrates signals from other TNF 
family members (46). Taken together, these data using KO mice demonstrate the 
crucial and non-redundant functions of LTα and LTβ in lymphoid organ development.   
 
1.2.1.2 TNF signalling 
TNF binds to TNFRI and TNFRII. TNFRI is expressed in most tissues and can be 
activated by membrane bound and soluble trimeric forms of TNF, whereas TNFRII is 
found mainly in cells involved in the immune system and responds to membrane 
bound TNF. Upon TNFR ligation the adaptor protein TRADD binds to the death 
domain upon the receptor and acts as a platform for further protein binding. Three 
signalling cascades are then initiated, activation of NF-kB and MAP kinase pathways 
and also the induction of cell death pathways. These pathways have conflicting effects 
with the activation of NF-kB considered anti-apoptotic and the activation of MAP 
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kinase and cell death pathways pro-apoptotic. This diverse signalling provides a 
mechanism by which varied responses can occur under different conditions (37). 
 
Tumour necrosis factor-related activation-induced cytokine (TRANCE), a TNF 
family member, is found on LTi cells and stromal cells within developing lymph 
nodes, and acts locally by attracting or differentiating LTi. Signalling via the 
TRANCE-R or the IL-7R initiates surface LT expression (47) and defects in these 
pathways affect the development of lymph nodes, with mice deficient for each 
receptor having unique phenotypes (48). Mice deficient in IL-7R signalling lack all 
Peyer‟s patches and only develop mesenteric and brachial lymph nodes (49). Whereas 
in mice lacking TRANCE-R, Peyer‟s patches are present with most lymph nodes 
missing (47). Interestingly TRANCE-R KO newborn mice still have LTi cells at sites 
where the mesenteric lymph nodes should have developed, but their numbers are 
severely reduced. This leads to a failure of most lymph nodes to develop, which 
suggests that there is a minimum number of LTi‟s required to initiate lymph node 
formation (47). The notion that there is a threshold number of LTi‟s is supported by, 
White et al, 2007, where a critical number of both LTi and stromal organiser cells was 
needed for normal inguinal lymph node development. Upon grafting E17 inguinal 
lymph nodes under the kidney capsule of adult mice, organisation of host T and B 
cells was observed, however inguinal lymph nodes grafted at E15 had no such 
organisation. This was thought to be due to the low numbers of LTi and mature 
stromal organiser cells at E15, as when a purified IL-7 cultured LTi population was 
added to a to the E15 inguinal lymph node cell suspension, lymphoid tissue formed 
upon kidney capsule grafting (50).  
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1.2.1.3 Lymphoid tissue organiser cells 
The stromal organiser cells of a lymph node express the LTβR. In mice, when this 
receptor is ligated, two sequential signalling pathways are initiated. The first signals 
via RelA, p50 and IκBα and initiates the expression of adhesion molecules such as 
VCAM-1 (51). Increased expression of VCAM-1 aids the interaction of the stromal 
organisers with the LTi cells. LTi cells in turn continue activation of the LTβR and 
trigger a second NF-κB pathway via the NF-κB-inducing kinase, IκB kinase α and 
RelB (51). This second pathway leads to production of chemokines such as CXCL13, 
CCL21 and CCL19 which mediate the clustering of LTi cells into specific areas 
within the lymph node anlagen (50,51). Stromal organiser cells are believed to 
develop from mesenchymal cells (section 1.2.1). It has been suggested that this 
mesenchymal specification of a lymph node organiser cell occurs independently from 
LTβR signalling. Specifically, LTβR-expressing stromal cells were shown to be 
present in normal numbers in rudimentary mesenteric lymph nodes from LTα KO 
mice at the day of birth, although they lacked VCAM-1 expression (52). A model 
incorporating these findings includes two separate lineage determination steps (figure 
1.5). First the mesenchymal cells differentiate towards stromal cells that produce 
TRANCE and then they are induced to express LTβR. Secondly the triggering of the 
LTβR by cells expressing LT (e.g. LTi) leads to up-regulation of adhesion molecules 
such as VCAM-1 and the production of chemokines. These cells can then attract and 
retain haematopoietic cells, allowing the lymphoid tissue to become colonised (45). 
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Figure 1.5 Differentiation of stromal organiser cells 
A model for the differentiation of the lymph node stromal organiser cell. An 
intermediate precursor arises from a mesenchymal stem cell which then differentiates 
into a lymph node organiser cell by the ligation of the LTβR. [Taken from Cupedo et 
al, 2005 (35)]. 
 
1.2.1.4 Lymph node developmental progression 
Lymph nodes have been demonstrated to develop in a certain order based on in vivo 
blocking experiments with LTαR-Fc. They begin at E10.5 with the mesenteric lymph 
nodes, next are the cervical at E11.5 and then the brachial and axillary after E12.5. 
The inguinal and Peyer‟s patches development begins at E16 but the Peyer‟s patches 
continue development until after birth. Finally after birth, the NALT develops 
(36,42,53). Each lymph node has their own set of developmental cues and signalling, 
as when different elements are blocked in the signalling pathway varying lymph 
nodes are affected. One explanation for the differences seen is a variation in the 
stromal cell compartment of each lymph node. It has been shown that, at least in the 
mesenteric and peripheral lymph nodes two populations of stromal cells exist; ICAM-
1, VCAM-1 and MadCAM high expressing cells (IVM
high
) and those expressing the 
same adhesion molecules at an intermediate level (IVM
int
) (45). The intermediate 
expressing cells were the larger population and these represented the previously 
described organiser cells. Both of these populations express LTβR, with the IVMint 
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population expressing a higher number of LTβRs. They also produced mRNA for 
homeostatic chemokines CXCL13, CCL19 and CCL21, with the IVM
int
 population 
expressing lower amounts. The expression profile of these populations identifies these 
cells as lymphoid tissue organisers. When comparing mesenteric lymph nodes to 
peripheral lymph nodes it was found that the IVM
int
 population was approximately 10 
fold reduced in the peripheral lymph nodes while the IVM
high
 was only slightly 
reduced. This finding may explain why these lymph nodes have different signalling 
requirements during embryonic development (45).  
 
1.2.1.5 Adult LTi 
It is clear that LTi – stromal cell crosstalk is required in the developing lymph node, 
however, whether this continues in adult secondary lymphoid organs is a key 
question. Cells equivalent to LTi have been found in adult mice, a key difference in 
the adult LTi is their expression of OX40 and CD30 (54). These adult LTi have been 
described as having a role in the generation of memory T cells (55) as well as having 
a role in the maintenance in secondary lymphoid tissue structure (56). Recent work 
has shown that LTi – stromal cell interactions persist in the adult and provide a 
significant mechanism for restoring secondary lymphoid organ integrity after 
infection (57). In a mouse model using infection with lymphocytic choriomeningitis 
virus (LCMV), the T zone stroma is destroyed, rendering the host particularly 
vulnerable to secondary infection. A study using this model demonstrated T zone 
stroma restoration through the proliferation of resident LTi cells and their interaction 
with lymphoid stromal cells. In addition, accumulation of LTi cells was seen in the 
spleen and lymph nodes coinciding with the peak of immunopathological damage. 
This accumulation was also shown to be as a result of LTi proliferation during the 
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infection. When LTi cells were removed from this system however, the restoration of 
normal splenic architecture post infection was delayed. This delay was also seen when 
LTβR signalling was blocked, suggesting that following infection, LTi – stromal cell 
cross talk is reactivated similar to that observed during embryonic development. Of 
importance, however, this study also showed that under normal conditions LTi cells 
were not required to maintain secondary lymphoid structure. Therefore it is possible 
that LTi cells present in the adult tissue are required only when considerable damage 
is sustained within the secondary lymphoid organs (57). More recently, in adult mice 
and humans, a population of IL-22 producing mucosal cells in mucosa-associated 
lymphoid tissues (MALT) have been described that share features of both LTi and 
NK cells, termed NK22 cells (58). In contrast to LTi cells, they express NKp46, a 
natural cytotoxicity receptor (59), but compared to NK cells express little or no 
classical NK markers such as NK1.1 and perforin (60). It has been suggested that LTi 
cells and NK cells come from a common precursor, with factors such as IL-15 and IL-
7 influencing the differentiation into NK or LTi cells and signals from the commensal 
microflora subsequently inducing the differentiation of NK22 cells from LTi cells 
(61). These cells are thought to be involved in immunity and homeostasis in mucosal 
tissues. 
 
1.2.2 Lymph node structure 
Two important vascular systems are found in the lymph node; lymphatic vessels and 
high endothelial venules (HEVs) (62,63). Immediately after birth, all HEVs express 
MAdCAM-1, the ligand for the integrin α4β7. This is rapidly replaced by peripheral 
lymph node addressin (PNAd) in mouse peripheral lymph nodes, functioning as the 
main L-selectin ligand that contributes to the mature peripheral lymph node HEV 
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phenotype. Conversely, in mucosal lymph nodes HEVs maintain their expression of 
MAdCAM-1 in addition to PNAd (64).   
 
The mature lymph node can be separated into three distinct regions: cortex, 
paracortex and medulla (figure 1.6). The cortex contains lymphoid nodules called 
primary follicles; these are composed of B cells and follicular dendritic cells (FDCs). 
It is here that the B cells undergo proliferation after antigen stimulation, forming 
secondary follicles termed germinal centres (65). Inside the cortex is the paracortex 
which is composed of T cells and DCs. The medulla consists of strings of 
macrophages and antibody secreting plasma cells known as the medullary cords. 
Lymphocytes enter the lymph node by extravasation across the HEV. Soluble antigen 
and DCs enter by afferent lymphatic vessels at multiple sites on the outer capsule 
(62,66).  
 
There are many types of stromal cell within the lymph node. Fibroblastic reticular 
cells (FRCs) in the T zone (67) and FDCs (68) and marginal reticular cells (MRCs) 
(69) in B cell zones. Also present in the CD45 negative cells of the lymph node are 
blood endothelial cells which express CD31 but not gp38 and lymphatic endothelial 
cells which express both gp38 and CD31 (67). 
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Figure 1.6 Lymph node structure 
The lymph node consists of three main regions; the cortex, paracortex and medulla. 
The cortex consists mainly of B cells organised as primary or secondary follicles. The 
migration of these cells towards the follicles is mediated by follicular dendritic cells 
(FDC). T cells migrate to the paracortical region, neighbouring the cortex, they 
interact with the interdigitating dendritic cells (IDC). The central region, the medulla, 
mostly contains plasma cells and B cells. The lymphocytes enter the lymph node via 
the afferent lymphatic vessel or through transmigration of the high endothelial 
venules (HEV). Both systems, the lymph vasculature and the blood vasculature, are 
connected via a conduit system. [Taken from Blum et al, 2006, (65)]. 
 
 
1.2.2.1 Lymph node T zone stroma 
Stromal cells support the distribution and migration of lymphocytes as well as acting 
as a structural backbone within the lymph node. T zone stromal cells, termed FRCs, 
produce constitutive chemokines and support migrating T cells and DCs. FRCs are 
more plentiful than other stromal populations within the lymph node and have been 
shown to express glycoprotein 38 (gp38 or podoplanin) (section 1.2.2.1.1) (70). They 
produce extracellular matrix (ECM) components which are crucial to the structural 
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stability of the lymph nodes and express CCL21 and CCL19 which attract the CCR7 
expressing T cells and DCs to the T zone. They also enhance the survival of T cells by 
producing IL-7 (71).  
 
1.2.2.1.1 Glycoprotein 38 (Podoplanin) 
A novel glycoprotein, gp38, was characterised by Farr et al, 1992, (72) and was later 
named podoplanin due to its low level expression in kidney podocytes (73).  gp38 is a 
mucin type transmembrane protein of 43kDa first found to be expressed by stromal 
cells of peripheral lymphoid tissue, in particular the FRCs of the T cell dependant area 
(72). In addition, gp38 is also expressed in other cells including lymphatic endothelial 
cells (74) and thymic epithelial cells (75). The gp38 KO mouse model shows 
increased embryonic and foetal death; in homozygote embryos, 40% die between 
stages E10-E16 and in the neonatal homozygotes, 50% die within the first weeks of 
life. This is in contrast to the heterozygous mice, which have been shown to reach 
sexual maturity. The causes of embryonic death have been linked to heart defects 
whereas the cause of neonatal death is still unknown (72,76). In other studies LTα1β2, 
produced by B cells, was shown to be required for gp38 expression. B cell deficient 
spleens had a three to five fold reduction in the area stained by CD3 and the T zone 
stroma marker gp38 (77). This indicates a role for B cells in the development of T 
zones in the spleen. In addition, impaired B and T cell segregation within the white 
pulp of the spleen correlates with a lack of gp38 expression on the T zone stroma, 
suggesting a role for gp38 in the separation of lymphocytes (78). Taken together, 
these findings suggest that gp38 is important in lymphatic patterning during 
development (74). 
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1.2.2.2 Lymph node B zone stroma 
The B zone consists of stromal cells and B cells, the main stromal cell being the FDC. 
FDCs produce CXCL13 which attract and retain CXCR5 expressing B cells to the B 
zone (68). The fibroblastic morphology of FDCs and their expression of vimentin and 
desmin suggests a mesenchymal origin (79). FDC development at sites of chronic 
inflammation indicates their differentiation from local mesenchymal cells (80). The 
ligands and receptors necessary for B cell growth and survival have been identified as 
TNF family members (81). B lymphocyte stimulator (BLyS), also known B cell 
activating factor (BAFF) or TNF13B, is produced by FDCs and plays a role in B cell 
survival and activation (82). 
 
More recently, a stromal cell population, termed MRCs was found in the outer 
follicular region immediately underneath the subcapsular sinus of lymph nodes in 
adult mice (69). These cells expressed VCAM-1, ICAM-1, MadCAM-1, CXCL13, 
TRANCE, BP-3 and gp38 and have been described as specialised reticular fibroblasts. 
These cells are thought to be the adult equivalent of embryonic LTo cells with a role 
in organising the structure of adult secondary lymphoid organs (69). 
 
1.2.2.3 The conduit system 
During infection lymph-borne antigens are first found in the subcapsular sinus of the 
lymph node. From here they are transported either directly into the medullary sinuses 
or into a reticular conduit system (figure 1.6). The conduit system has been described 
as the infrastructure of the lymph node, transporting fluid and low molecular weight 
molecules (<70kDa) (83). It is a network of collagen fibres ensheathed by FRCs, 
which extends from the subcapsular sinus to the deeper cortex and medullary regions, 
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suspending blood vessels and sinuses (84). The FRCs produce collagen and basement 
membrane components that form a highly organised core around which the FRCs are 
wrapped, they are also connected along the longitudinal axis by junctional complexes. 
In places where the basement membrane is not covered by FRCs, DCs are positioned, 
which enables them to gain access to antigens that have entered the conduit (85). This 
structure means lymphocytes are not in contact with the basement membrane, only the 
FRC membrane, hence the FRCs have an important role in the guidance of 
lymphocytes. More recent work has shown that the conduit network does not act as a 
barrier to lymphocyte migration but rather as an active support and provider of 
guidance cues underlying T and B cell movement within the T zone of lymph nodes 
(86). The conduit system is involved in the movement of antigen before it is sampled 
by APCs, such as DCs, and therefore has a functional role in antigen presentation 
(87). Small molecules such as chemokines can also be moved through the conduit 
system, with peripherally produced chemokines able to drain into the conduit system. 
These can then be presented on the luminal side of HEVs which will ultimately affect 
leucocyte entry (88). The spleen also contains a conduit system, which is similar to 
that of the lymph node, with the only major difference being that it is not connected to 
the lymphatic system but to the blood (84). Further work within the spleen has shown 
that movement within the conduit system is not just dependent on size but also on the 
molecule‟s 3-D configuration or electrostatic charge (83). 
 
1.2.3 Splenic development 
Relative to the lymph node, splenic development has been poorly characterised with 
fewer studies completed. There remains a large gap in the literature to be filled. The 
spleen is normally situated on the left side of the abdominal cavity, closely associated 
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with the pancreas and located on the left lateral side of the stomach. During 
development the leftward expansion of the mesenchyme provides the tissue in which 
the spleen forms, with the initiation of splenogenesis and leftward pancreatic growth 
closely linked (89). Splenic development in mice begins at E9.5 with the formation of 
the splanchnic mesodermal plate (SMP). The SMP, which is derived from mesoderm, 
is an anlage or organising centre for the formation of the spleen. In conditions where 
the SMP is defective the spleen does not form, for example mice carrying the 
dominant hemimelia mutation or a deficiency in bagpipe homeobox homologue 1 
(89,90). The first cells to colonise the spleen are the progenitors of the erythroid and 
myeloid lineages. Later, at E13.5, LTi cells are present in the spleen. These are known 
to provide the inductive signal for the formation of lymph nodes and may therefore 
have a role in white pulp formation. Finally at E14.5 the first haematopoietic cells 
reside in the spleen (91). 
 
1.2.4 Splenic structure 
The spleen is the largest single secondary lymphoid organ in mammals. It has a role in 
both innate and adaptive immunity and also in the removal of senescent red blood 
cells. The two roles are compartmentalised in two distinct components, the red pulp 
and the white pulp. The afferent splenic artery branches into central arterioles which 
are sheathed by white pulp areas. The arterioles end in cords in the red pulp where the 
blood runs into the venous sinuses and collects in the efferent splenic vein. A capsule 
surrounds the spleen and contains the connective tissue trabeculae in which the larger 
arteries and veins run (figure 1.7a) (92). 
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Figure 1.7 Structure of the spleen 
a) Cross sectional schematic of the human spleen. b) A comparison of the white pulp 
in a mouse and human spleen. The main differences are found in the structure of the 
marginal zone, which surrounds the white pulp. In contrast to mice, humans have an 
inner and an outer marginal zone, which is surrounded by a large perifollicular zone. 
[Taken from Mebius et al, 2005 (92)]. 
 
1.2.4.1 Red pulp 
The red pulp consists of large numbers of sinuses and sinusoids filled with blood; its 
main function is to remove damaged or aging erythrocytes. Arterial blood flows into 
cords in the red pulp that consist of fibroblasts and reticular fibres with no endothelial 
lining. The blood then flows into the venous sinuses of the red pulp, which collect 
into the efferent vena lienalis. These vessels are lined with endothelium but it has a 
discontinuous structure. Stress fibres run along the long axis of the endothelium and 
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are most prominent during contraction. This structure forces the blood from the cords 
into the sinuses through slits formed by the stress fibres. As erythrocytes age, their 
membranes become rigid, causing slower migration through these stress fibres, 
thereby enabling phagocytosis by local macrophage (92). In both humans and mice 
adult erythropoiesis occurs in the bone marrow. However, it is important to note that 
stress erythropoiesis occurs in the murine splenic red pulp during embryonic 
development and acute anaemia (93).  Splenic erythropoiesis is not a feature of human 
haematopoiesis, extramedullary erythropoiesis is only seen in certain pathological 
conditions such as primary myelofibrosis (94). 
 
1.2.4.2 White pulp 
The white pulp consists of aggregates of lymphoid tissue and is responsible for the 
immunological function of the spleen. It is present in the form of a periarteriolar 
lymphoid sheath (PALS), containing B cell follicles and a T cell zone. At the edge of 
the T zone is a region known as the marginal zone where larger lymphocytes and 
antigen presenting DCs are located (figure 1.7b) (92). The white pulp closely 
resembles the structure of the lymph node, one major difference being that lymph 
nodes collect antigen from the periphery via afferent lymphatics, whereas the spleen 
receives antigen directly from the blood (62,95). The splenic organisation is 
maintained by specific chemokines that attract the T and B cells to their respective 
zones. Like in the lymph node, CXCL13 here produced by CD35
+
FDCs and their 
adjacent stromal cells, induce B cells to migrate to the B cell zones via interaction 
with CXCR5 (96). Signalling through CXCR5 on the B cell induces expression of 
LTα1β1. This then induces differentiation of neighbouring FDCs and their expression 
of CXCL13 creating a positive feedback loop (97). The B cells expression of LTα1β1 
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also induces CCL21 expression by stromal cells which is vital in the recruitment and 
retention of T cells in the T cell zones. Along with CCL21, CCL19 is also involved in 
attracting T cells and DCs to the T zones via interaction with CCR7 (98).  
 
LTα has also been found to have a role upstream of these chemokines. LTα deficient 
mice do not have the normal segregation of B and T cell zones and the average size of 
the white pulp is decreased. The formation of FDC clusters and germinal centres 
within the white pulp of the spleen does not occur within these mice, which also lack 
lymph nodes and Peyer‟s patches. In addition LTα KO mice do not have the marginal 
zone of monoclonal antibody (MOMA-1) staining, which highlights metallophilic 
macrophages. This is in contrast to the TNFR-1 deficient mice, suggesting that LTα 
can regulate certain aspects of the splenic white pulp through other receptors (99). 
Interestingly, when BM transplantation was utilised, the LTα deficient mouse 
demonstrated that although LTα is vital for the initial segregation of B and T zones, it 
is not crucial for maintaining the structure (100,101). This was in contrast to the 
generation and continuance of FDC clusters within the spleen, which was shown to be 
LTα dependent (102).  
 
In the spleen both innate and adaptive immune responses can occur, the white pulp is 
involved in adaptive immunity whereas the marginal zone is involved in both innate 
and adaptive immunity (92). An important property of the spleen is that most of the 
blood flow passes through the marginal zone and then along the white pulp, making 
the spleen a very efficient monitor of the blood. A critical role of the spleen is 
protection against blood-borne pathogens, splenectomy due to infection, inflammation 
or trauma, leads to a lifelong requirement for antibiotics (103).    
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1.3 Inflammation 
Inflammation is a basic mechanism of our immune system. It is an attempt by the 
body to restore and maintain homeostasis after injury and is an integral part of body 
defences. Most defence elements are transported in the blood and inflammation is the 
means by which these elements leave the blood and enter the tissue around the injured 
or infected site. Inflammation plays three important roles in combating an infection, it 
delivers additional effector molecules, provides a physical barrier to prevent 
spreading and promotes the repair of injured tissue (6). The signs of inflammation 
were first described by Celsus over 2000 years ago as calor, dolor, rubor and tumor 
(2). Acute inflammation is essentially beneficial; however, excess or prolonged 
inflammation can cause harm. Chronic inflammation is an inflammatory response 
characterised by the infiltration of mononuclear cells, tissue destruction, angiogenesis 
and fibrosis. Persistent inflammatory diseases lead to the development of long-lasting 
or frequently recurring inflammation, for example rheumatoid arthritis (RA) (section 
1.4.4.1), lupus, and inflammatory bowel disease (2). 
 
1.3.1 Acute Inflammation 
An acute inflammatory response is a normal process in response to injury or infection. 
It is characterised by local dilation of blood vessels and increased vessel permeability 
to improve blood flow to the area. Acute inflammation is primarily mediated by 
neutrophils, which are the first leucocytes to enter the injured site (2). 
 
Normally after a pathogen has been eliminated the immune response ceases and so the 
inflammation subsides and is cleared. Clearance of the acute inflammatory response 
involves apoptosis of the vast majority of the infiltrating leucocytes with subsequent 
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phagocytosis and tissue structure and function returning to normal (2,104). Acute 
inflammation is also under strict endogenous control involving anti-inflammatory 
mediators which reverse vascular changes and inhibit leucocyte migration and 
activation. Examples of anti-inflammatory mediators include cytokines IL-1, IL-4, IL-
10 and TGF-β (6). In addition, there are also pro-resolution agonists that do not just 
inhibit the inflammatory cascade, as anti-inflammatory mediators do, but actively 
dismantle it. Pro-resolution agonists include lipoxins, resolvins and protectins (105). 
Lipoxins have been described as early braking signals for inflammation, increasing 
apoptotic neutrophil phagocytosis, decreasing adhesion molecule activation and 
decreasing migration of neutrophils and eosinophils (106,107). Cyclopentenone 
prostoglandins have also been shown to play a role in the resolution of inflammation 
through repression of pro-inflammatory macrophage function (108). 
 
1.3.2 Chronic Inflammation 
Prolonged inflammation ceases to be beneficial and can contribute to the pathogenesis 
of many diseases. Chronic inflammation is primarily mediated by monocytes and 
long-lived macrophages. Later stages involve the persistent accumulation of 
lymphocytes suggesting a distorted balance between mechanisms that increase cell 
number, recruitment, retention and proliferation and those that decrease cell number, 
emigration and death (figure 1.8) (10). For example, clearance of the inflammatory 
infiltrate by apoptosis can be inhibited by anti-apoptotic factors present in the local 
microenvironment, such as joints of patients with RA. Interaction with synovial 
fibroblasts upregulated Bcl-xL but not Bcl-2 and thereby prevented T cell apoptosis 
(109). Type 1 interferons, which are produced by synovial fibroblasts and 
macrophages in RA, have also been demonstrated as a survival factor for T cells. 
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Thereby increasing the number of T cells in the joint (110). As well as increased 
survival, inappropriate retention of T cells has also been observed. Upregulation of 
CXCR4 on T cells and it‟s ligand CXCL12 on stromal cells within the RA joint 
caused the T cells to be retained within the chronic inflammatory site rather than 
emigrating (111). Lymphocyte egress requires sphingosine 1-phosphate receptor-1 
(S1P1) (112), IFNα and β have been found to inhibit lymphocytes responsiveness to 
sphingosine 1-phosphate by inducing cell surface activation marker CD69. S1P1 
forms a complex with CD69, promoting downmodulation and inhibiting lymphocyte 
egress (112). 
 
 
Figure 1.8 Dynamic balance of cell accumulation 
(a) During a normal inflammatory response homeostasis is maintained and 
inflammation resolved (b) In chronic persistent inflammation inappropriate retention 
of leucocytes occurs as fibroblasts and other resident stromal cells produce pro-
retentive (CXCL12) and pro-survival (IFN-β) factors. [Taken from Buckley et al, 
2001, (113)]. 
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1.3.2.1 Lymphoid neogenesis in inflammation  
During chronic inflammation a specialised type of lymphogenesis can occur, which 
results in tertiary lymphoid neogenesis. Kratz et al (1996), demonstrated a unified 
model for lymphoid organ structure development during chronic inflammation based 
on LTα expression (104). Tertiary lymphoid organs arise under environmental 
influences and are the ectopic accumulations of lymphoid cells. It is important to note 
that these structures have many similarities to secondary lymphoid organs especially 
lymph nodes (figure 1.9). They arise randomly in adult peripheral tissue often in non-
lymphoid locations and have been found in immune diseases (114), microbial 
infection (115) and chronic allograft rejection (116). In addition, transgenic mouse 
models of chronic inflammation that over express inflammatory cytokines, for 
example TNF and LTα have been shown to develop these structures (117). In diseases 
such as RA, where chronic inflammation occurs, cytokine and chemokine expression 
is constitutive. It is under these conditions that tertiary lymphoid organs are found in 
the joints of a RA patients but why they form and the molecular basis for their 
persistence is unknown (35,118). Stromal cells, in particular fibroblasts, contribute to 
the microenvironment in chronic inflammation, by providing pro-survival and 
retention signals via production of factors such as TGF-β and CXCL12. As such they 
have been implicated in the formation of tertiary lymphoid tissues (110,111). 
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Figure 1.9 Secondary and tertiary lymphoid tissues 
(a) Secondary lymphoid tissues; hematoxylin and eosin stain of normal spleen, lymph 
node and tonsil architecture (b) Tertiary lymphoid tissues; hematoxylin and eosin 
stain of inflamed synovium in Rheumatoid arthritis, salivary gland in Sjogrens 
syndrome and thyroid gland in Hashimoto‟s thyroditis. [Pictures courtesy of Dr 
Debbie Hardie and Dr Karim Raza, Division of Immunity and Infection, University of 
Birmingham]. 
 
1.4 The Fibroblast 
Stroma is an important structural component of vertebrate animals. It consists of 
ECM, mesenchymal cells and a scaffold consisting of blood and lymphatic vessels, 
nerves and inflammatory cells (119). The most abundant cell type of tissue stroma is 
the fibroblast (120) (figure 1.10). Fibroblasts are traditionally identified by their 
spindle shaped morphology and their ability to adhere to plastic in vitro (121). 
Fibroblasts are ubiquitous cells that provide mechanical strength to tissues by 
producing ECM components which form a supporting framework. These components 
include type I, III and V collagen and fibronectin (122). They also produce factors 
that are involved in the formation of basement membranes such as type IV collagen 
and laminin (123). Fibroblasts have a role in ECM homeostasis as they not only 
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produce the ECM components but also the proteases that degrade it and regulate its 
turnover, such as metalloproteinases (MMPs) (124).  
 
 
Figure 1.10 A migrating fibroblast 
Red = β-actin mRNA, Green = β-actin protein and Blue = nuclear staining. [Taken 
from Dahm et al, 2005, (125)]. 
 
1.4.1 Fibroblast origin 
Fibroblasts are believed to arise from three distinct cellular origins: primary 
mesenchyme, local epithelial-mesenchymal transition (EMT) or bone marrow derived 
precursors.  
 
It is widely accepted that the majority of fibroblasts originate from primary 
mesenchymal cells and that upon the appropriate stimulation these fibroblasts can 
proliferate to generate new fibroblasts (126). Local EMT is a central mechanism for 
diversifying cells in the formation of complex tissues (figure 1.11) (127). Fibroblasts 
can be derived by this process in adult tissue following epithelial stress such as 
inflammation or tissue injury. Essentially EMT disaggregates epithelial cells and 
reshapes epithelia for movement. The epithelium loses polarity, adherens junctions, 
tight junctions, desmosomes and cytokeratin intermediate filaments. They also 
rearrange their F-actin stress fibres producing filopodia and lamellopodia (127). A 
combination of cytokines associated with digestion of the basement membrane is 
believed to instigate EMT, as well as MMPs (128) and TGF-β (129). However, the 
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order of importance of the cytokines involved during inflammation is still unclear as 
many are present in significant amounts at the site. EMT also contributes to the 
growing premise that fibroblasts are not a homogeneous population and are a much 
more active and heterogeneous cell population than first appreciated (130-132). 
 
Generation of fibroblasts has also been reported from precursor cells called fibrocytes. 
These cells represent ~0.05% of circulating blood cells that are believed to arise from 
CD14
+
 peripheral blood monocytes (133). They express both haematopoietic and 
stromal cell markers and are thought to differentiate into fibroblasts at inflammatory 
or wound sites (134,135). All three of these processes appear to contribute to the 
pathological accumulation of fibroblasts (126,127,136,137). 
 
Figure 1.11 The cellular variation arising from EMT 
Epithelia undergo EMT to form the cells of connective tissue, including astrocytes, 
adipocytes chondrocytes, osteoblasts, muscle cells, and fibroblasts. These processes 
are regulated by morphogenic cues and a variety of transcription factors. [Adapted 
from Kalluri et al, 2003, (138)] 
 
1.4.2 Identifying fibroblasts 
Research into fibroblasts has lagged behind that of other cell types, partly due to their 
phenotypic and functional heterogeneity but also their plasticity in differentiation 
capacity (section 1.4.3). Moreover, a lack of selective markers for isolating and 
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discriminating between fibroblast subtypes has hampered previous studies. Therefore, 
the lack of markers for other cell lineages is used to indicate the presence of a 
fibroblast i.e. non-lymphoid, non-endothelial and non-epithelial. Currently a panel of 
markers are used to identify fibroblasts but as none are exclusive to fibroblasts they 
can provide only an indication. This panel includes intermediate filament associated 
protein Vimentin, the relatively newly isolated cell surface protein CD248 (section 
1.4.2.1), α-smooth muscle actin (SMA) and VCAM-1. A comprehensive list can be 
found in table 1.1 (138). 
Marker Function Fibroblast types in 
which it is found 
Other cell types in 
which it is found 
Vimentin Intermediate filament 
associated protein 
Miscellaneous Endothelial cells, 
myoepothelial cells, 
neurons 
α-SMA Intermediate filament 
associated protein 
Myofibroblasts Vascular smooth muscle 
cells, pericytes, 
myoepithelial cells 
Desmin Intermediate filament 
associated protein 
Skin fibroblasts Muscle cells, vascular 
smooth muscle cells 
FSP1 Intermediate filament 
associated protein 
Miscellaneous Invasive carcinoma cells 
Discoidin-
domain 
receptor 2 
Collagen receptor Cardiac fibroblasts Endothelial cells 
FAP Serine protease Activated 
fibroblasts 
Activated melanocytes 
α1β1 integrin Collagen receptor Miscellaneous Monocytes, endothelial 
cells 
Prolyl 4-
hydroxylase 
Collagen biosynthesis Miscellaneous Endothelial cells, cancer 
cells, epithelial cells 
Pro-collagen 
1α2 
Collagen-1 
biosysnthesis 
Miscellaneous Osteoblasts, 
chondroblasts 
CD248 
 
Unknown Miscellaneous Pericytes 
VCAM-1 Cell adhesion Miscellaneous Activated endothelial 
cells 
 
Table 1.1 Fibroblast indicators 
Markers used to identify fibroblast cells [adapted from Kaluri et al, 2006, (138)]. 
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1.4.2.1 CD248 
CD248, also known as endosialin or tumour endothelial marker-1 (TEM-1) has been 
described as a marker of interstitial fibroblasts in human (139) and mouse (140) 
tissues. It was identified after screening for monoclonal antibodies (mAbs) that 
recognise proteins with a fibroblast-restricted distribution. CD248 is found in its 
immature form within the Golgi network, it is then modified by approximately 95kDa 
of highly sialylated O-linked oligosaccharides to form the 175kDa mature protein 
(139). In addition, CD248 is expressed on a subset of pericytes, a relatively 
undifferentiated cell associated with the walls of small blood vessels (141). 
Expression of CD248 on pericytes as well as interstitial fibroblasts, suggests that they 
may have been recruited from a stromal fibroblast population or that they are 
undergoing fibroblast differentiation (139).  
 
CD248 is part of a family of molecules implicated in tissue remodelling and repair, 
including CD93 and CD141 (142,143). It has been demonstrated to be involved in 
development, showing high expression in the embryo which decreases postnatally 
(140,144). Although this pattern of expression has been observed in many tissues, 
variations in expression were noted between different lymphoid tissues, suggesting 
site specific expression (140,145). Interestingly, a role for CD248 in remodelling has 
been suggested. When challenging a mouse with Salmonella infection, induced 
splenomegaly occurs, which is associated with complete remodelling of the splenic 
architecture. Upon remodelling of the spleen CD248 expression is significantly 
increased which then decreases upon resolution of the infection (140). These findings 
suggest that populations of CD248 expressing fibroblasts are involved in embryonic 
development and the remodelling of tissues in the adult. Loss of CD248 expression 
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due to siRNA-mediated silencing showed a decrease in fibroblast proliferation and 
migration (146). Studies in the CD248 KO mouse confirmed these effects on 
migration and proliferation as tumour growth, invasiveness and metastasis was 
reduced in abdominal sites (147). However normal tumour growth was seen in 
tumours implanted in subcutaneous sites, again indicating site specific expression. In 
addition, CD248 expression has been observed on mesenchymal stromal cells (MSCs) 
(section 1.4.4.3) and it has been postulated that CD248 can be used as a marker for 
MSCs (146,148). 
 
1.4.3 Fibroblast heterogeneity 
The difficulty of finding specific fibroblast markers is further complicated as 
fibroblasts isolated from different anatomical sites exhibit different functional 
properties, such as altered migratory capacity, ECM production, degradation and 
contractility (149). Previous work in our group, identified two groups of human 
fibroblasts based on their gene and protein expression. These were termed typical 
(peripheral) and atypical (lymphoid) fibroblasts (figure 1.12) (150). It was shown that 
upon stimulation with inflammatory mediators such as TNFα, IL-4 and IFNγ the gene 
expression of the typical fibroblast could be modified such that they adopt features of 
atypical fibroblasts. This finding strongly suggests that inflammation can, at least 
transiently, alter fibroblast gene expression profiles (150).   
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Figure 1.12 Principle component analysis of peripheral and lymphoid fibroblasts 
Using whole genome microarrays, fibroblasts can be grouped based on their gene 
expression into typical and atypical fibroblasts. [Adapted from Parsonage et al, 2003, 
(136)]. 
 
Moreover, gene expression profiles of primary human fibroblasts have shown large 
scale differences related to three broad anatomical divisions; anterior-posterior, 
proximal-distal and dermal-nondermal (151). A set of 337 genes was found to vary 
according to these divisions. This set included genes involved in pattern formation, 
cell-cell signalling and matrix remodelling. Interestingly, HOX gene expression was 
differentially expressed according to the location where the fibroblasts were isolated. 
Specifically HOXA13 was found to maintain the distal specific transcriptional 
programme in adult fibroblasts (figure 1.13). More recently Rinn et al, (2008) 
demonstrated that in serially passaged fibroblasts HOX gene expression levels were 
stable for at least 35 passages in vitro. Within the same study they also found that 
addition of cultured medium from one fibroblast culture to another from a different 
site did not affect the clustering of these genes and a clear separation between sites 
was still observed. In addition, co-culturing different fibroblasts together did not alter 
Chapter One Introduction 40 
their gene expression. This suggests that secreted factors from adult fibroblasts are 
unable to reprogramme the site-specific gene expression of other fibroblasts, implying 
that the majority of site-specific gene expression in fibroblasts is controlled by a cell-
autonomous epigenetic mechanism (152). 
 
Taken together, these data suggest that the gene expression profile of adult human 
fibroblasts may play a significant role in assigning positional identity within an 
organism (151,152) and has led to the proposal of a stromal address code, analogous 
to that of an endothelial address code (153). In this hypothesis, the fibroblasts posses a 
gene expression profile specific for their anatomical position. This gene expression 
profile could be an important source of molecular landmarks for site specific 
differentiation, by constructing an identifiable ECM expressing structure and cell 
surface proteins that provide site specific signalling for a given anatomic origin (151).  
The stromal address code hypothesis therefore provides an attractive mechanism for 
the switch from resolving to chronic inflammation, as an altered code could cause 
inappropriate recruitment, retention or proliferation of leucocytes. 
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Figure 1.13 Human fibroblast gene expression patterns 
(a) A total of 47 primary cultures representing 43 unique anatomic sites (grey circles) 
that map the human body were profiled by gene expression microarrays. (b) Model of 
fibroblast differentiation by overlapping positional patterns of gene expression: 
proximal (yellow), distal (orange), anterior (blue), posterior (green) and internal 
organs (red). (c) A decision tree of HOX expression that distinguish unique anatomic 
positions. Right: red indicates higher-than-average and green lower-than-average 
expression of a given HOX gene, relative to the average expression level across 47 
cultures. Each anatomic site can be correctly identified by monitoring the expression 
level of three HOX genes or less. Left: the developmental axes that demarcate site-
specific gene expression of fibroblasts: anterior–posterior, proximal–distal and 
dermal–non-dermal. A third developmental axis, dorsal–ventral, did not correlate with 
large-scale site-specific gene expression in fibroblasts. [Taken from Rinn et al, 2008, 
(154)]. 
 
 
1.4.4 The function of fibroblasts 
It is becoming clear that fibroblasts play not only an active role in defining the 
structure of tissue microenvironments but also modulating immune cell behaviour by 
conditioning the local cellular content and cytokine production, specifically tailoring 
the response to the cause of the damage (113). 
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Fibroblast activation leads to the production of appropriate cytokines, chemokines and 
prostanoids such as PGE2 (138). Fibroblasts can also regulate the behaviour of 
haematopoietic cells present in damaged tissue, CD40-CD40 ligand interaction lead to 
activation of the NF-κB family of receptors, causing fibroblasts to synthesise high 
levels of IL-6, IL-8, cyclooxygenase-2 and the polysaccharide hyaluronan (155). This 
mechanism is analagous to the cross talk that occurs between lymphocytes and APCs, 
suggesting a role for fibroblast and leucocyte crosstalk during an immune response. 
Therefore as fibroblasts are relatively long lived it is important that their activation is 
tightly regulated (156-158). Fibroblasts have been shown to contribute to the 
pathology of many diseases, either directly for example by overproduction of matrix 
components during fibrosis and/or indirectly by influencing the behaviour of 
neighbouring cell types (159-161). 
 
1.4.4.1 The role of fibroblasts in rheumatoid arthritis 
Rheumatoid arthritis is the most common chronic inflammatory disease affecting 
approximately 1% of the population worldwide
 
(162). The main feature of RA is 
persistent joint inflammation. The disease is characterised by inflammation and 
hyperplasia of the synovial membranes of diarthrodial joints in a symmetrical fashion 
(163). This causes pain and joint failure and can eventually lead to disfiguration and 
disability (164,165). Over 20 years ago fibroblasts isolated from diseased tissues were 
shown to be phenotypically different from those taken from normal tissue. 
Fassbender, (1983) described subpopulations of fibroblasts within the synovial 
membrane which showed morphological and biological differences (166). In RA, 
specifically, fibroblasts are thought to play a key role in the pathogenesis of the 
disease, as synovial fibroblasts are not only different between healthy and RA patients 
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but also between the layers of the rheumatoid synovium (155). Fibroblasts from the 
lining layer have features of cell activation and are believed to result in aggressive, 
invasive behaviour. This has been demonstrated in vivo using co-implantation of 
fibroblasts and cartilage under the kidney capsule. Fibroblasts from RA synovium 
invade cartilage when implanted together whereas fibroblasts from osteoarthritis or 
healthy patients do not (167). In addition, these fibroblasts also appear to differ 
morphologically, with a more rounded shape, a larger pale nucleus and prominent 
nucleoli. Differences in shape were further reported in RA patients, where a 
reorganisation of the actin cytoskeleton and disregulation of ECM adhesion was 
observed (155). As well as the phenotypic changes, synovial fibroblasts from RA 
patients have also been shown functionally to affect the accumulation and survival of 
lymphocytes in the joint by increasing survival and recruitment of T cells (109). The 
properties of these fibroblasts suggest a transformed cell phenotype and lead to the 
hypothesis that the rheumatoid synovium is a locally invasive tumour (168,169). 
 
1.4.4.2 The role of fibroblasts in cancer 
The microenvironment surrounding malignant cells is named the tumour stroma, this 
consists of non-malignant cells, ECM and growth factors embedded in the ECM 
(170). Fibroblasts are a component of the tumour stroma and have also been shown to 
have a role in cancer at all stages including progression (171), growth (172) and 
metastasis (173). Specifically, at the site of a tumour the surrounding fibroblasts 
remain continuously activated and have a modified phenotype. It is believed that they 
may facilitate angiogenesis and cancer progression, such fibroblasts have been named 
cancer-associated fibroblasts (CAFs) (138). In breast carcinomas, approximately 80% 
of stromal fibroblasts are thought to have this activated phenotype, expressing α-SMA 
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and have been termed myofibroblasts. Myofibroblasts and CAFs produce increased 
amounts of MMPs, affecting ECM turnover and altering the ECM composition (174). 
A source of CAFs may be EMT (section 1.4.1) from cancer cells and also normal 
epithelial cells, this process has been recognised as an important factor in cancer 
progression and may also modulate the progression by providing fibroblasts-like cells 
with an altered genome (175). The stromal elements of a tumour have, in recent 
studies, shown significant prognostic value. The stromal gene signature found could 
be used alone or in combination with existing techniques to improve molecular 
classification and outcome prediction, such as patients who would respond better to 
aggressive treatment (176). 
 
1.4.4.3 Fibroblasts and their relationship to MSC 
Mesenchymal stem cells (MSCs) are typically found in the bone marrow but can also 
be expanded from a wide variety of adult and fetal tissues (177,178). MSCs are 
multipotent stem cells that can differentiate into a variety of cell types including 
osteoblasts, chondrocytes and adipocytes (179). In recent literature, it is important to 
note that the terms mesenchymal stem cell and mesenchymal stromal cell have been 
used interchangeably. Whether they describe an identical cell type remains 
controversial. Of relevance to this thesis, it has been found that MSCs can suppress 
virtually all immune cell responses. For example they can suppress T cell 
proliferation, induce T cell anergy and apoptosis and modulate cytokine production 
through the production of soluble factors (180). A role for IFN-γ in the 
immunosuppression mediated by stromal cells has been suggested. IFN-γ induces 
indoleamine 2,3-dioxygenase (IDO) which accelerates tryptophan degradation, 
thereby suppressing T cells (181). However, to distinguish fibroblasts from MSCs is 
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difficult as cell surface antigens used to define MSCs are also expressed on fibroblasts 
(182). Fibroblasts have also been found to have the potential to differentiate into other 
cell types such as adipocytes, osteocytes and chondrocytes and effect proliferation and 
survival of lymphocytes (120). Despite this it may be that all stromal or fibroblast-like 
cells have immunosuppressive potential. A study by Jones et al (2007) supports this 
theory as they conclude that immunosuppressive effect is a fundamental characteristic 
of all stroma (183).  
 
MSCs have been described as a heterogeneous population and it is quite plausible that 
fibroblasts such as those described previously by our group and Rinn et al, 2008 may 
be termed mesenchymal stromal cells (183). 
 
1.5 Hypothesis 
Previous work by our group has proposed that in addition to the well described 
endothelial area code fibroblasts help define a stromal postcode that regulates 
leucocyte survival, retention, proliferation and differentiation within tissues (136). 
Inappropriate expression of all or parts of the code may be involved in the switch 
from resolving to persistent inflammation.  
 
The hypothesis is that fibroblasts derived from different murine lymphoid sites have 
site specific gene and protein expression and that this results in functional differences 
during interactions with other cell types and products.  
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1.6 Aims of thesis 
The main aims of this thesis were to: 
a) identify whether mouse fibroblasts from lymphoid and peripheral organs 
have site specific gene expression as reported in the human studies (151) 
and if so what genes are site defining.  
b) determine whether LTα stimulation affects this pattern of gene 
expression, for example inducing a more lymphoid like profile in 
peripheral fibroblasts.  
c) consider the functional relevance of these differing fibroblast gene 
expression profiles in the mouse by using in vivo models of organ grafting 
under the kidney capsule and assessing leucocyte accumulation in 
differing fibroblast microenvironments. 
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CHAPTER TWO 
Materials and Methods 
 
2.1 Media, solutions and other reagents 
All reagents were purchased from Sigma Aldrich (Poole, UK) unless otherwise stated. 
 
2.1.1 Complete fibroblast medium  Dulbecco‟s Modified Eagles Medium 
10% Fetal Calf Serum 
2mM glutamine 
100U/ml penicillin 
100g/ml streptomycin 
 
2.1.2 Washing medium   RPMI 1640 
10% Fetal Calf Serum 
 
2.1.3 Phosphate buffered saline (PBS) Dissolve 1 tablet in 100ml distilled water 
-autoclave at 115°C for 10 minutes. 
 
2.1.4 Tissue digestion buffer               RPMI 1640 
10% Fetal Calf Serum 
1mg/ml Collagenase/Dispase (Roche 
Diagnostics, Germany) 
20µg/ml DNase  
 
2.1.5 Red blood cell lysis buffer (pH 7.2) 1 litre dH20 
      8.29g NH4Cl (0.17M) 
1g KHCO3 (1µM) 
      37.2mg EDTA (1mM) 
 
2.1.6 10x Annexin V staining buffer 100ml dH20 
      0.1M HEPES 
      1.4M NaCl 
      25mM CaCl2 
 
2.1.7 Freezing medium   Fetal Calf Serum 
      10% Dimethyl sulfoxide 
 
2.1.8 TBE buffer    89nM Tris HCL 
      89nM Boric Acid 
      3mM EDTA 
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2.1.9 1% Agarose gel   4g Agarose (1%) 
      400mls TBE Buffer 
      40µl ethidium bromide (10mg/ml) 
 
2.1.10 Hoechst nuclear counterstain 1µl Hoechst bisBenzimide 332382 
(10mg/ml) 
1ml PBS 0.05% azide  
 
2.1.11 1, 4-diazabicyclo[2.2.2]octane  2.4g DABCO 
           (DABCO)     10mls PBS 
 
   
  
2.2 Antibodies 
 
2.2.1 Isotype controls 
 
 
Isotype Format Source 
Rat IgG1 PE SouthernBiotech 0116-09 
Rat IgG2a Fitc eBioscience 11-4321-82 
Rat IgG2b APC BD Pharmingen 556924 
Rat IgG2b PE BD Pharmingen 553989 
Rat IgG2b Biotin eBioscience 13-4031-82 
Rat IgG2b Fitc eBioscience 11-4032-82 
Rabbit IgG uncongugated Dako x0903 
Armenian Hamster IgG Fitc SeroTec MCA2356F 
Armenian Hamster IgG1 uncongugated eBioscience 14-4888-81 
Mouse IgG1 uncongugated Dako x0931 
 
 
Table 2.1 Isotype control antibodies 
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2.2.2 Anti-mouse primary antibodies 
 
 
 
Table 2.2 Primary antibodies 
 
 
 
Antigen 
Isotype Format Source Working 
Dilution 
(confocal) 
Working 
dilution 
(FACS) 
α-SMA 
Mouse 
IgG2a, κ 
Purified Lab Vision 
UK 
1/50 - 
B220 
Rat IgG2a, 
κ 
Fitc eBio 11-
0452-85 
1/200 1/200 
Caspase-3 
Rabbit IgG Purified BD 
Pharmingen 
559565 
1/50 - 
CD3 
Hamster 
IgG 
Fitc eBio 11-
0031-85 
1/50 1/100 
CD11c 
Hamster 
IgG 
Fitc eBio 11-
0114-82 
1/50 1/50 
CD31 
Rat IgG2a Fitc eBio 11-
0311-81 
1/50 1/100 
 
CD45 
Rat IgG2b, 
κ 
PE BD 
Pharmingen 
553081 
- 1/200 
CD45 
Rat IgG2b APC BD 
Pharmingen 
550864 
- 1/300 
CD54 
Rat IgG2b, 
κ 
PE eBio 12-
0541-81 
- 1/1500 
CD248 
Polyclonal 
Rabbit IgG 
Purified pre-
absorbed 
JRM 1/50 1/50 
F4/80 
Rat IgG2b Fitc SeroTec 
MCA497F 
1/50 1/50 
gp38 
Hamster 
IgG 
Uncongugated Kind gift 
from Andy 
Farr (72) 
1/5 1/50 
PDGF-Rα 
Rat IgG2a, 
κ 
Biotin eBio 13-
1401-82 
1/100 - 
VCAM-1 
Rat IgG1, κ Biotin SouthernBiot
ech 1510-08 
1/50 1/100 
Vimentin 
Mouse 
IgG1, κ 
Uncongugated Lab Vision 1/50 1/50 
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2.2.3 Secondary antibodies 
 
 
Antigen Source 
Working 
Dilution 
(confocal) 
Working 
Dilution 
(FACS) 
Donkey anti Goat Alexa 
546 
Molecular Probes A11056 1/100 - 
Donkey anti Goat Cy5 
Jackson Immunoresearch 
705-176-147 
1/100 - 
Donkey anti Goat Cy2 
Jackson Immunoresearch  
705-226-147 
1/100 - 
Donkey anti Goat Fitc 
Jackson Immunoresearch  
705-096-147 
1/200 - 
Donkey anti Sheep 
Jackson Immunoresearch   
713-176-147 
1/200 - 
Goat anti Rat Alexa 546 Molecular Probes A11081 1/100 - 
Goat anti Rabbit Alexa 633 Molecular Probes A21072 1/100 - 
Goat anti Mouse Alexa 488 Molecular Probes A21121 1/100 - 
Goat anti Mouse IgG2a 
Tritc 
Southern Biotech 1080-03 1/50 - 
Goat anti Hamster Cy5 
Jackson Immunoresearch 
107-176-142 
1/100 - 
Goat anti Fitc 488 Molecular Probes A11096 1/100 - 
Goat anti Rabbit PE Southern Biotech 4050-09 - 1/100 
Goat anti mouse IgG1 Fitc Southern Biotech 6061-02 - 1/100 
Goat anti hamster Fitc Southern Biotech 1072-02 - 1/75 
Rabbit anti Rat Biotin Dako E0468 1/100 - 
Streptavidin Alexa 546 Molecular Probes S-11225 1/50  
Streptavidin Alexa 633 Molecular Probes S21375 1/100 - 
 
Table 2.3 Secondary antibodies 
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2.3 Mice 
All experiments were performed in accordance with UK laws and with the approval of 
the University of Birmingham ethics committee. All mice were bred and maintained 
in the Biomedical Services Unit (BMSU) at the University of Birmingham. 
 
2.4 Cell culture 
Required tissues were isolated from mice by dissection under sterile conditions; 
routinely spleen, liver, thymus, skin, lung and inguinal, axillary and cervical lymph 
nodes were taken. The tissues were stored in 2mls of RPMI/10%FCS on ice. These 
were then either non-enzymatically (section 2.4.1.) or enzymatically (section 2.4.2) 
digested for culture. All cells were cultured in complete fibroblast medium (section 
2.1.1) and maintained at 37°C, 5% CO2, with media changed every 3-4 days. 
 
2.4.1 Non-enzymatic digestion 
Tissues were mashed directly on a sterile 50µm-nylon filter gauze in a Petri dish with 
approximately 200μl of complete fibroblast medium (section 2.1.1) using a 5ml 
syringe plunger. The gauze was then washed with a further 2ml complete fibroblast 
medium and the cell suspension transferred to a 6 or 24 well plate; 6 well plates were 
routinely used with 24 well plates used for those organs where a small cell suspension 
was obtained e.g. lymph nodes. Complete fibroblast medium was then added to the 
well to a total volume of 4mls per well in a 6 well plate and 2mls per well in a 24 well 
plate. Cell cultures were washed in PBS (section 2.1.3) after 7 days to remove cell 
debris and all non-adherent cells. 
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2.4.2 Enzymatic digestion 
Bone marrow flushes were collected, centrifuged at 300g for 5 minutes at 4°C and 
resuspended in 2mls tissue digestion buffer (TDB) (section 2.1.4). All solid organs 
were cut into small pieces and incubated at 37°C in 2ml TDB for a maximum of 40 
minutes, resuspending the cells every 5 minutes by pipetting. The quality of the cell 
suspension was checked every 10 minutes microscopically. Once a single cell 
suspension was obtained 1ml of washing medium (section 2.1.2) was added and the 
cells centrifuged at 300g for 4 minutes at 4°C. Cells were resuspended in 1ml 
complete fibroblast medium (section 2.1.1) and transferred into 6 or 24 well plates as 
in section 2.4.1. Cell cultures were washed in PBS (section 2.1.3) after 7 days to 
remove cell debris and all non-adherent cells. 
 
2.4.3 Passaging 
Once 90-100% confluence was reached cultures were washed with PBS and passaged 
using a 2X trypsin-ethylene-diamine-tetra-acetic acid (EDTA) solution (Sigma). Once 
cells had detached, as assessed microscopically, fresh complete fibroblast medium 
(section 2.1.1) was added to neutralise the trypsin and the resulting cell suspension 
centrifuged at 300g for 4 minutes at 4C. The cells were then either resuspended in 
33% conditioned fibroblast medium diluted with fresh complete fibroblast medium 
for continued culture or in 1 ml of culture medium ready for long term storage 
(section 2.4.4). 
 
2.4.4 Freezing of cell cultures for long term storage 
Cells resuspended in 1ml of culture medium as described in section 2.4.3 were 
counted using trypan blue (Sigma) and then centrifuged at 300g for 4 minutes at 4C. 
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Cells were resuspended in freezing medium (section 2.1.7) and stored at -80°C for 24 
hours after which they were then transferred to liquid N2 for long term storage. The 
number of cells frozen was then used to compare with the number of live cells 
obtained post-recovery from storage as described in section 2.4.5. 
 
2.4.5 Cell recovery from long term storage 
Cells were defrosted at 37C, reconstituted in 12ml of complete fibroblast medium 
(section 2.1.1) and centrifuged at 300g for 4 minutes at 4C. The cell pellet was then 
resuspended in 1ml complete fibroblast medium and the number of live cells were 
counted using trypan blue. The number of live cells being brought up per vial was 
recorded for comparison with number frozen down. The cells were then maintained at 
37C in a 5% CO2 atmosphere. 
 
2.4.6 Cell imaging 
During their time in culture, cells were imaged in 6 well plates at x10 magnification 
using the Axiover 200 microscope (Zeiss, Germany). Images were processed using 
capture (AIC) software (Digital Pixel, UK). 
 
2.4.7 Cell sorting 
Cells were sorted into two populations based on their CD45 expression using the 
MoFlow Cell Sorter (Coulter). Briefly, cells were lifted from the plate using a non-
enzymatic cell dissociation buffer (Gibco). The cells were centrifuged at 300g at 4°C 
for 8 minutes and resuspended in tissue digestion buffer (section 2.1.4) for 10 minutes 
at 37°C to negate cell clumping. The cells were washed, pelleted as above, re-
suspended in 500µl RPMI 10% FCS containing anti-mouse CD16/32 (1:50) to block 
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Fc receptors on the cells and incubated on ice for 20 minutes. The cells were then 
centrifuged at 300g for 8 minutes at 4°C and resuspended with 220µl of RPMI 
10%FCS. Two 10µl aliquots of cells were then added to 190µl of RPMI 10%FCS for 
the unstained and irrelevant controls, with the remaining to be stained with the 
antibody of interest. Antibodies (section 2.2.1 and 2.2.2) were added to the respective 
tubes and incubated on ice for 30 minutes after which, the cells were washed with 
RPMI 10% FCS and pelleted before being filtered through a 50µM filter to remove 
any clumped cells or debris. The cells were then sorted based on their CD45 
expression using the MoFlow Cell Sorter (Coulter). Sorted cells were resuspended in 
complete fibroblast medium (section 2.1.1) and transferred into 6 or 24 well plates for 
culture. 
 
2.5 RNA extraction 
Using the RNeasy mini kit (QIAgen, 74965) RNA extraction was performed as per 
the manufactures instructions. Briefly, pelleted, trypsinised cells (section 2.4.3) were 
lysed by 600µl of a highly denaturing guanidine-thiocynate-containing buffer, 
containing 1% β-mercaptoethanol, which immediately inactivates RNases to ensure 
purification of intact RNA. The lysate was then homogenised using a QIAshredder 
spin column (QIAgen, 79654). Genomic DNA was removed from each sample using 
the RNase-free DNase kit (QIAgen, 79254) according to the manufactures 
instructions. Purified total RNA was eluted with 30µl of RNase-free water, the 
concentration determined using a spectrophotometer (BioPhotometer, Eppendorf) and 
stored at -80°C. 
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2.5.1 cDNA preparation 
Complementary DNA (cDNA) was synthesised using the smart PCR cDNA synthesis 
kit (BD Biosciences, K1052-1) as per the manufacturer‟s instructions. Briefly, 5µg of 
total RNA was incubated with 3µg of oligo-dN6 to prime for cDNA synthesis for 10 
minutes at 70C, after which the reaction was stopped by placing it on ice. Reverse 
transcription (RT) was performed for 1 hr at 41°C with the enzyme deactivated by 
incubating the mixture at 90°C for 10 minutes; using the following master mix; 
1.25l H2O 
6l 5X first strand buffer 
3l 0.1M DTT 
1.5l dNTP (10mM)  
0.75l RNAse Inhibitor (RNAguard, Pharmacia, ~40 U/l) 
1.5l M-MLV (Gibco) (1 l/g RNA, stock 200 U/l) 
The cDNA was stored at 4C for up to a week and -20C for longer periods. 
 
2.5.2 Polymerase chain reaction (PCR) 
Using cDNA as the template (section 2.5.1), PCR was performed using ReddyMix 
manufactured by ABIgene (AB-0575-LDb), along with primers for the gene of 
interest. Reactions were carried out using a PCR Sprint Thermal Cycler (Hybaid 
systems, Waltham, MA). The general programme used was: 92°C for 2 minutes, 30 
cycles of 92°C for 15s, 65°C for 30s and 70°C for 45s. Then finally 72°C for 5 
minutes. Cycle number and the annealing temperature were dependent on the primers 
being used (table 2.4). The PCR products obtained were then analysed by running on 
a 1% (w/v) agarose gel containing EtBr (section 2.1.9) in a TBE running buffer 
(section 2.1.8). One microgram of one hundred base pair molecular weight markers 
were also run on each gel (Roche Diagnostics, Germany). The DNA bands were 
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visualised using a Syngene ultraviolet (UV) transilluminator (Cambridge, UK) and 
identified by product size. 
Gene Primer sequences 5’ – 3’ 
Annealing 
temperature 
(°C) 
Number of 
cycles 
Product 
size (base 
pairs) 
β-actin 
F:ATCTACGAGGGCTATGCTCTCC 
55 30 148 
R:CTTTGATGTCACGCACGATTTCC 
BP-3 
F: AGGGACAAGTCACTGTTCTGG 
55 34 105 
R: AACTTTGCCATACAGCACGTC 
CCL7 
F: TCTGTGCCTGCTGCTCATAG 
55 34 81 
R: TTGACATAGCAGCATGTGGAT 
CCL11 
F: CACGGTCACTTCCTTCACC 
55 34 76 
R: GGTCATGATAAAGCAGCAGGA 
CCL19 
F:ACTCACATCGACTCTCTAGG 
60 30 370 
R:ACTCACATCGACTCTCTAGG 
CCL21 
F: TCCCGGCAATCCTGTTCTC 
60 30 249 
R:TTCTGCACCCAGCCTTCCT 
CD3 
F: TGCCTCAGAAGCATGATAAGC 
60 35 200 
R: GCCCAGAGTGATACAGATGTCAA 
CD19 
F: GGAGGCAATGTTGTGCTGC 
60 35 164 
R: ACAATCACTAGCAAGATGCCC 
CD31 
F:CATGATGCCAAGTCTGAGA 
55 35 165 
R:GTGGGCTTATCTGTGAATGT 
CD248 
F:TTCCCACTCCCAAATCAGTG 
56 30 480 
R:GAGTCCTGGTGTGCCTTTG 
CXCL1 
F: CTGGGATTCACCTCAAGAACATC 
55 34 117 
R: CAGGGTCAAGGCAAGCCTC 
CXCL12 
F: GCTCTGCATCAGTGACGG TA 
55 34 163 
R: TGTCTGTTGTTGTTCTTCAGC 
CXCL13 
F: TGAGGCTCAGCACAGCAA 
55 34 77 
R: ATGGGCTTCCAGAATACCG 
EpCAM 
F: GCGGCTCAGAGAGACTGTG 
60 34 139 
R: CCAAGCATTTAGACGCCAGTTT 
F4/80 
F:CTTTGGCTATGGGCTTCCAGTC 
56 30 165 
R:GCAAGGAGGACAGAGTTTATCGTG 
FOXN1 
F:CTCGTCGTTTGTGCCTGAC 
55 34 243 
R:TGCCTCTTGTAGGGGTGGAAA 
gp38 
F:ACCGTGCCAGTGTTGTTCTG 
56 30 159 
R:AGCACCTGTGGTTGTTATTTTGT 
ICAM-1 
F: GTGATGCTCAGGTATCCATCCA 
55 34 213 
R: CACAGTTCTCAAAGCACAGCG 
Lhx8 
F: GAGCTCGGACCAGCTTCA 
55 34 67 
R: TTGTTGTCCTGAGCGAACTG 
IL-6 
F: GCTACCAAACTGGATATAATCAGGA 
55 34 78 
R: CCAGGTAGCTATGGTACTCCAGAA 
IL-7 
F:TTCCTCCACTGATCCTTGTTCT 
55 34 200 
R:AGCAGCTTCCTTTGTATCATCAC 
IL-15 
F:TCTCCCTAAAACAGAGGCCAA 
55 34 125 
R:TGCAACTGGGATGAAAGT 
IL-17RA 
F: AGTGTTTCCTCTACCCAGCAC 
55 34 194 
R: GAAAACCGCCACCGCTTAC 
IL-17RF 
F: TGCCATTCTGAGGGAGGTAG 
55 34 205 
R: GGGGTCTCGAGTGATGTTGT 
IL-22R 
F:CATTGCCTTCTAGGTCTCCTC  
55 34 134 
R:CCTGCTTGCCAGTGCAAAAT 
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LTα 
F:GATGCCATGGGTCAAGTGCT 
55 34 136 
R:GCTTGGCACCCCTCCTGTC 
LTβR 
F:GAGCAGAACCGGACACTAGC 
55 34 255 
R:GAAGGTAGGGATGAGCACC 
Lyve-1 
F:CGCCCATGATTCTGCATGTAGA 
55 34 112 
R:CAGCACACTAGCCTGGTGTTA 
Meox2 
F: AATCTAGACCTCACTGAAAGACAGG 
55 34 73 
R: CTTTGACCCGCTTCCACTT 
PDGFRα 
F: TGGCATGATGGTCGATTCTA  
55 34 152 
R: CGCTGAGGTGGTAGAAGGAG  
PDGFRβ 
F: TTCCAGGAGTGATACCAGCTT 
55 34 104 
R:AGGGGGCGTGATGACTAGG 
Prox-1 
F:GGCATTGAAAAACTCCCGTA 
55 34 279 
R:CGGACGTGAAGTTCAACAGA 
Prrx1 
F: AGTCACCGGGACTGACCA 
55 34 72 
R: TCTTCTCCTCAGAGTTCAACTGG 
TNFR1 
F:ATGTACACCAAGTTGGTAGC 
55 34 213 
R:AATATCCTCGAGGCTCTGAGA 
TRANCE 
F:TGCTAATGTTCCACGAAATG 
55 34 102 
R:ATTCAGGTGTCCAACCCTTCC 
TSLP 
F:ACGGATGGGGCTAACTTACAA 
55 34 128 
R:AGTCCTCGATTTGCTCGAACT 
VCAM-1 
F:GACCTGTTCCAGCGAGGGTCTA 
56 30 122 
R:CTTCCATCCTCATAGCAATTAAGGTG 
VEGFa 
F: GCAGCTTGAGTTAAACGAACG 
55 35 94 
R: GGTTCCCGAAACCCTGAG 
VEGFc 
F: CAGACAAGTTCATTCAATTATTAGACG 
55 35 73 
R: TGTCTTGTTAGCTGCCTGACAC 
 
Table 2.4 Primer sequences and conditions 
 
2.6 Real time PCR (Q-PCR) 
Gene expression profiles of purified total RNA from cell cultures were analysed using 
the Quantitech Probe one-step Q-PCR kit (QIAgen, 204443) in combination with 
TaqMan Low Density Arrays (www.appliedbiosystems.com). A working solution of 
50% Quantitech buffer, 1% Quantitect RT-PCR enzyme mix and 49% total RNA was 
prepared per sample; typically 100μl buffer, 2μl enzyme and total RNA sample 
diluted to 98μl in RNase-free water. Approximately 95µl of each sample‟s working 
solution was then pipetted into two ports of the card. The cards were then centrifuged 
twice at 300g for 1 minute to allow adequate distribution of the sample over the 
probes. The plate was then sealed and the ports cut off. The Applied Biosystems 
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7900HT Fast Real-Time PCR System was used to perform the real time-PCR with the 
following cycle conditions: 50°C for 30 minutes, 94.5°C for 15 minutes and the 40 
cycles of 96°C for 30 seconds and 59.7°C for 1 minute. 
 
Data was analysed using SDS 2.2 (Applied Biosystems). Relative quantification of 
signal per cell was achieved by setting thresholds within the logarithmic phase of the 
PCR for the control gene and the target gene. The cycle number (Ct) at which the 
threshold was reached was then determined. The Ct for the target gene was subtracted 
from the Ct for the control gene and the relative quantity was calculated as 2
-∆CT
.  RT-
PCRs using identical primers and probes run in separate plates were analysed together 
with the same threshold and baseline settings so that they could be compared. 
 
2.7 Microarrays 
Whole mouse genome arrays of 37,632 genes (AROS version 4.0, Operon, USA) 
were printed by Liverpool Microarray Facility (Liverpool University, England). 
 
2.7.1 cDNA amplification 
For use with microarrays first strand cDNA was synthesised and amplified from 
approximately 0.05-1ug of total RNA. The protocol supplied for the SMART cDNA 
synthesis kit (BD biosciences, K1052-1) was utilised with the following adaptations: 
3‟SMART CDS Primer II A (sequence 5‟-
AAGCAGTGGTATCAACGCAGAGTACT(30)N-1N-3‟ (Invitrogen); SMART II A 
oligonucleotide (sequence 5‟-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3‟, 
(Invitrogen); 5‟ PCR primer II A (sequence 5‟-
AAGCAGTGGTATCAACGCAGAGT-3‟ (Invitrogen); superscript II reverse 
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transcriptase (Invitrogen) and its accompanying 1
st
 strand buffer used in place of 
Powerscript reverse transcriptase. 
 
After amplification the cDNA was purified using NucleoSpin Extract II (Macherey 
Nagel, 740609.250) following the kit instructions, with cDNA eluted in 50µl H2O. 
The eluted cDNA was then quantified by measuring absorbance at 260nm with a 
spectrophotometer (BioPhotometer, Eppendorf) and purity assessed visually by β-
actin PCR on an electrophoresis gel. All cDNA was stored at -20°C. 
 
2.7.2 CyDye labelling of cDNA 
Cy3-dCTP and Cy5-dCTP labelling was performed using 10µl of sample cDNA. To 
do this 20µl of random primer mix (Bioprime Labelling Kit, Invitrogen, 18094-011) 
and 13µl deionised H2O was added. The mix was heated to 94°C for 5 minutes and 
then cooled on ice for the addition of other reagents. 
 
The following was then added: 1.2µl 10mM dATP; 1.2µl dTTP; 1.2µl dGTP; 0.72µl 
dCTP (100mM dNTP Set PCR Grade, Invitrogen 10297-018); 0.68µl H2O; 1µl of 
either Cy3 dCTP (sample) (Amersham Biosciences, PA53021) or Cy5 dCTP 
(reference) (Amersham Biosciences, PA55021); 1µl 40U/µl Klenow enzyme 
(Bioprime Labelling Kit, Invitrogen, 18094-011). The reaction was then incubated at 
37°C for 8 hours. 
 
The labelled cDNA was purified by means of NucleoSpin Extract II (Macherey 
Nagel, 740609.250) as per the instructions eluting in 70µl H2O. The quantity of 
labelled cDNA was then assessed using a spectrophotometer by calculating 
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absorbance at 550nm (Cy3-dCTP) or 650nm (Cy5-dCTP). The yield in pmol was 
calculated by the following: 
 
For Cy3 = Abs550 x 50µl/0.15 
 
For Cy5 = Abs 650 x 50µl/0.25 
 
The labelled cDNA was then stored in the dark at 4°C before hybridisation. 
 
2.7.3 Array hybridisation and analysis 
GAPS II coated slide arrays (Corning, 40006) were pre-hybridised as per the 
instructions using formamide (Sigma, F-9037) with the pre-hybridisation solution for 
2 hours at 42°C. The pre-hybridised slide was dipped in H2O, and spun to dry. It was 
then placed into a corning hybridisation chamber (Corning, 2551) and the preparation 
instructions for the chamber followed. 
 
Labelled cDNA (100pmols) from test and reference samples was taken, mixed and 
concentrated using Microcon YM-30 concentration columns, as per the instructions, 
(Millipore, 42410) eluting in a final volume of 30µl H2O. 50µl of cDNA mix 
containing 5µg PolyA DNA and 8µg Cot1 DNA as nucleic acid-blockers and 
formamide was added to the 30µl labelled probe and the mix denatured at 95°C for 5 
minutes. The probe mix was then applied to the surface of the slide and a Lifter Slip 
(VWR International, 7370042) applied. The hybridisation chamber was then closed, 
wrapped in a damp paper towel and foil and hybridised at 42°C for 16-20 hours. After 
hybridisation the slides were immersed in 2x saline-sodium citrate (SSC) buffer + 
0.1% SDS at 42°C to remove the coverslip. The slide was then subsequently washed 
for 5 minutes at 42°C in 2 x SSC + 0.1% SDS, followed by 5 minutes room 
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temperature in 0.2 x SSC and four 5 minutes room temperature washes in 0.05 x SSC. 
Finally, slides were dipped into H2O and centrifuged at 500g for 15 minutes at room 
temperature to dry. 
The arrays were then scanned using Scan Array GX Plus (Perkin Elmer) and software 
Scan Array Express (Perkin Elmer) and aligned manually. MultiExperiment Viewer 
version 4.0 (TM4 Software Suite) was used to analyse the data obtained. Hierarchical 
clustering was performed to group samples together based on the similarity of their 
gene expression profiles. Significance analysis of microarrays (SAM) was used to 
find the genes significantly different between the samples. This is based largely upon 
the student T-test with the addition of a false discovery rate (FDR). The relative 
difference (d(i)) was compared to the distribution of d(i) following random 
permutation of the sample categories. For each d(i), a certain proportion of all genes 
in the permutation set (control set) will be found to be 'significant' by chance and this 
parameter was then used to calculate a FDR. The FDR was set to 10% when SAM 
analysis was completed. 
 
2.8 Indirect-immunofluorescent staining 
Cells to be used for immunofluorescence analysis were grown in 8-well chamber 
slides (BD Biosciences, 354108). Once confluent, the media and chambers were 
removed, slides washed in PBS for 5 minutes at room temperature and left to air dry 
for 1 hour. The cells were fixed in 100% acetone at 4°C for 20 minutes, allowed to 
dry at room temperature for 10 minutes and stored at -80°C for future use.  
 
When staining, the slide was removed from the freezer and defrosted at room 
temperature. Each cell area was drawn round with a hydrophobic pen to prevent 
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leakage and placed in PBS for 10 minutes to re-hydrate the cells. Cells were blocked 
with 10% goat serum diluted in PBS/2%BSA for 10 minutes at room temperature to 
prevent non-specific binding. Cells were then incubated with primary or irrelevant 
control antibodies in PBS/2%BSA (sections 2.2.1 and 2.2.2, respectively). 
Subsequently, the slides were washed in PBS for 10 minutes and cells incubated with 
secondary antibody in PBS/2%BSA (section 2.2.3). All incubations were at room 
temperature, for 1 hour in a humidity chamber, with fluorophores protected from 
light. Finally, the slides were washed in PBS for 10 minutes and incubated with the 
nuclear counterstain Hoechst (section 2.1.10) for 2 minutes to visualise cell nuclei. 
The sections were then mounted with glycerol containing anti-fade reagent, DABCO 
(section 2.1.11), a coverslip was added and slides stored at -20°C. Cell staining was 
visualised using a LSM510 confocal microscope (Zeiss, Germany) at x10 or x40 
magnification. Images were captured and processed using Zeiss LSM image software 
(Zeiss, Germany). 
 
2.9 Flow cytometry 
 All flow cytometry on stromal cells was performed using an EPICS XL Flow 
Cytometer (Beckman Coulter). The Dako Cyan-ADP high performance flow 
cytometer (Colorado, US) was used with all other cells. 
 
The analysis of specific surface molecules from freshly isolated cells was achieved 
using standard flow cytometry techniques. Briefly, cells were resuspended at 
1x10
6
/ml in PBS/2%BSA. Approximately 1x10
5
 cells were transferred into a fetal calf 
serum (FCS) coated well of a 96 well round-bottomed plate to reduce adherence of 
the cells to the plate. These were washed, pelleted by centrifuging at 300g for 4 
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minutes, and then re-suspended in PBS/2%BSA containing anti-mouse CD16/32 
(1:20) to block Fc receptors on the cells. The plate was then incubated on ice for 20 
minutes after which cells were pelleted and resupended in primary antibody (section 
2.2.2) and incubated on ice for a further 20 minutes. The cells were then washed twice 
with 150µl PBS/2%BSA and resuspended in secondary antibody (section 2.2.3) or 
PBS 2%BSA (depending on whether immunofluorescence was direct or indirect) and 
incubated on ice for 20 minutes.  Finally the cells were washed as above and 
transferred to FCS-coated FACS tubes in a total volume of 400µl. For each antibody 
irrelevant controls (section 2.2.1) were also performed using the same working 
concentration. The cells were then run through the EPICS XL Flow Cytometer 
(Beckman Coulter) or the Dako Cyan-ADP high performance flow cytometer 
(Colorado, USA). Flow cytometry data was analysed using WinMDI software 
(version 2.8, Scripps Research Institute, La Jolla, CA) or Summit software (version 
4.3, Dako, Colorado, USA). 
 
2.10 Lymphotoxin α treatment 
CD45 negative stromal cells were seeded at 5x10
4
 in a 24-well plate in 500µl of 
complete fibroblast medium (section 2.1.1). After 24 hours the medium was replaced 
with 500µl of fresh complete fibroblast medium containing 1µg/ml lymphotoxin (LT) 
α. Control wells with no LTα were also carried out. After 24 hours the stromal cells 
were washed in PBS and removed from the plate by incubating with 1ml cell 
dissociation buffer (Gibco) for 20 minutes at 37°C, 5%CO2. The cells were then 
stained for VCAM-1 and ICAM-1 expression using flow cytometry (section 2.9). 
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2.11 Cellular co-culture 
CD45 negative stromal cells were seeded at 3x10
5
 in a 6-well plate in 3mls of 
complete fibroblast medium (section 2.1.1).  After 24 hours 1.5mls of conditioned 
medium from the cultures was added to a fresh well and a further 1.5mls of fresh 
complete fibroblast medium was added to every well. 3mls fresh complete fibroblast 
medium was also used as a control. A spleen, taken from a C57BL6 mouse was 
mashed through a 0.22µm filter, the cells washed and resuspended in red blood cell 
lysis buffer (section 2.1.6) for 10 minutes on ice. The lymphocytes were then counted 
and resuspended in complete fibroblast medium. 1x10
6
 lymphocytes isolated from the 
spleen were added to each well. The plate was then incubated at 37°C, 5% CO2. After 
4 days the wells were washed vigorously and the splenocytes stained for flow 
cytometry (section 2.9). The percentage of viable cells was also determined by flow 
cytometry with Annexin V. Post antibody incubations, cells were washed in cold 
PBS, followed by a single wash in Annexin V staining buffer (section 2.1.6). The 
cells were then pelleted as above, resuspended in 100µl of the staining buffer, 
containing Annexin V Fitc antibody (5:200) and incubated on ice for 20 minutes. The 
cells were then analysed by flow cytometry (section 2.9). 
 
2.12 Reaggregates 
Reaggregates were formed using 1x10
5 
cells/200µl complete fibroblast media (section 
2.1.1) in a well of a V-well plate (Sterilin, UK). The plate was then centrifuged at 
900g for 5 minutes at room temperature and again at 225g for 5 minutes at room 
temperature, to ensure complete formation of the pellet. The plate was then placed at 
37°C/5%CO2 for 24 hours prior to use. For the LTα treated reaggregates, 1µg/ml LTα 
was added to the media in the V-well plate during the formation of the reaggregate. 
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When using the collagen sponge for structural support, 1x10
5
 cells in 50µl of 
complete fibroblast media were added to the sponge (2-3mm
3
) (Pfizer, UK) and 
incubated at 37°C/5%CO2 for 2 hours prior to use. 
 
2.12.1 Grafting under the kidney capsule 
Cell reaggregates (section 2.12) were grafted under the kidney capsule of a 6-8 week 
old C57BL6 mouse (figure 2.1). Mice were anaesthetised using 4% Isofluorane (May 
and Baker, Dagenham, UK) carried in oxygen. Pre-operative Buprenorphine 
(Temgesic, AnimalCare, York, UK) was administered sub-cutaneously using a 
syringe fitted with a 25 Gauge needle at a dose of 2mg/kg. The fur was removed from 
the left lumbar region using clippers and area cleaned with 70% ethanol (figure 2.1A). 
A small cut was made in the left lower lumbar region approx 0.5-1cm in length 
depending on the size of the mouse, using surgical blunt ended scissors (F.S.T) (figure 
2.1B). Scissors were used to make space between the skin and peritoneum before 
making a similar size cut in the peritoneum. Blunt forceps were used to locate the 
kidney, which was then eased out of the body cavity using the fat attached to the 
lower end, the kidney was kept moist using gauze soaked in PBS (figure 2.1C). Sharp 
forceps were used to pierce a small hole in the capsule of the kidney, and open up a 
small space beneath the capsule. The reaggregate was then placed under the capsule 
with up to three reaggragates placed under each kidney capsule. The edges of the skin 
and peritoneum were lifted from beneath the kidney to allow it to slip back into the 
abdominal cavity. The peritoneum was closed with at least two stitches using size 5, 
round-bodied, vicryl sutures (Johnson and Johnson Intl). The skin was cleaned using a 
cotton bud dipped in PBS and the wound closed with a clip (VetTech Solutions, UK) 
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(figure 2.1D). The grafts were removed and analysed by immunofluorescence (section 
2.8) after 1-4 weeks. 
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Figure 2.1 Kidney capsule transfer 
Reaggregates were inserted under the kidney capsule of adult C57BL6 mice after (A) 
anaesthetising the mouse, (B) removing the fur from the left flank of the mouse and 
making a small cut through the skin and peritoneum and (C) manoeuvring the kidney 
out of the body cavity. Up to three stromal cell reaggregates were grafted under one 
kidney capsule (C) before the wound was closed with sutures and a clip (D). [Pictures 
courtesy of Dr Stephanie Glanville, Division of Immunity and Infection, Birmingham 
UK]. 
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2.13 Statistical analysis 
Statistical analysis of flow cytometry data was carried out using GraphPad Prism 
computer software (GraphPad Software, Inc., San Diego, CA) and performing a 
paired T-test.
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CHAPTER THREE 
 
Characterisation of Fibroblasts from Lymphoid and Peripheral Sites in the 
Adult Mouse 
 
3.1 Introduction 
Fibroblasts are a heterogeneous population that can arise from at least three different 
pathways. They differentiate from mesenchyme, arise by epithelial-mesenchymal 
transition (EMT) or from bone marrow derived precursor cells (127). Their gene 
expression profile in humans has been found to be site-specific and it is possible to 
group fibroblast populations based on three anatomical divisions: anterior-posterior, 
proximal-distal and dermal-nondermal (151). This site specific gene expression is 
thought to be controlled by a cell-autonomous mechanism, as culturing fibroblasts 
from one site with conditioned medium from another did not alter the expression of 
the genes used to group them. Co-culturing fibroblasts from different sites was also 
unsuccessful at modifying gene expression (152). Previous work from this group has 
looked at human fibroblast gene expression and the changes in our gene expression in 
response to certain cytokines which mimic Th1, Th2 and inflammatory stimuli. It was 
reported that inflammation can, at least transiently, alter a fibroblasts gene expression 
profile (150).  
 
In this chapter fibroblast heterogeneity in several mouse organs was investigated by 
comparing cell morphology, gene expression and protein expression. By fully 
characterising these cells the aim was to group fibroblasts by anatomical site of origin 
based on the criteria previously described in the human studies (151). Stromal cells 
were successfully cultured from the spleen, thymus, liver, skin, lung and inguinal, 
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axillary and cervical lymph nodes of 6 week old female C57BL6 mice. Site specific 
differences were observed between these cultures in cell morphology, protein 
expression and gene expression.  
 
3.2 Results 
3.2.1 Fibroblast characterisation 
Stromal cells were isolated from the spleen, liver, thymus and inguinal, axillary and 
cervical lymph nodes from 6 week old female C57BL6 mice. Female mice were 
chosen as in human studies a female predominance is found in autoimmune diseases 
(184) and the age of 6 weeks old was used to ensure the lymphoid system was fully 
developed after birth (62). To isolate cells from tissues, both mechanical and 
enzymatic digestion protocols were tested. Enzymatic digestion with collagenase, 
dispase and DNase (section 2.4.2) proved to be more consistent at obtaining a 
confluent monolayer than non-enzymatic digestion (section 2.4.1) and thus was used 
throughout the study (data not shown). Selection for stromal cells was based on their 
ability to adhere to plastic, with non-adherent cells removed after 7 days, and 
proliferate.  
 
3.2.1.1 Fibroblast morphology 
From the outset it was clear that the enzymatically digested cell cultures derived from 
different organs were morphologically different from each other (figure 3.1). They 
demonstrated heterogeneity not only in cell shape but also in size, suggesting that 
these cultures may also contain different cell types. The digestion was reproducible as 
three different mice gave similar findings (figure 3.2). 
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Figure 3.1 Stromal cell culture heterogeneity 
Images from cell cultures derived from different organs at passage two after six weeks 
in culture, (a) spleen (b) thymus (c) liver (d) inguinal lymph node (e) axillary lymph 
node (f) cervical lymph node. Heterogeneity seen is representative of 3 independent 
cultures for each organ. Images taken at x10 magnification. 
 
 
 
Figure 3.2 Splenic stromal cell culture heterogeneity 
Images from splenic stromal cells at passage two after six weeks in culture. 
Demonstrating the heterogeneity observed within three separate cultures (a-c). Images 
taken at x10. 
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3.2.1.2 Fibroblast gene expression 
The TaqMan low density array (LDA) is a customisable 384-well micro fluidic card, 
designed for use with the Applied Biosystems 7900HT Fast Real-Time PCR System, 
to perform hundreds of real-time PCR reactions simultaneously (section 2.6). To 
determine the gene expression profiles of the cultured cells described in section 
3.2.1.1 a Fibroblast LDA was used containing a variety of genes. This included 
stromal cell associated genes, for example VCAM-1, vimentin and collagen type 1 
and 3 isoforms, TNF family genes which are important in stromal cell interactions 
with many cell types, genes expressed by other cell lineages for elimination purposes 
and housekeeping genes such as β-actin as controls (appendix 8.1).  
 
To analyse gene expression data from each of the cell cultures, RNA was extracted at 
passage four to six and approximately 1µg was hybridised to the Fibroblast LDA. 
Following real-time PCR all data was normalised to the expression of β-actin 
(appendix 8.2). Significance analysis of microarrays (SAM) analysis (section 2.7) was 
used to determine the gene expression that differed significantly between the cultures 
(figure 3.3a). There were 28 differentially expressed genes (table 3.1), these included 
TNF family members, interleukins and cytokine receptors. Genes indicative of the 
presence of other cell types such as CD86 expressed on antigen presenting cells (185) 
and CD80 expressed on activated B cells and monocytes (186) were observed in 
lymphoid organ cultures. CD117 which is expressed on haematopoietic stem cells 
(187) and PECAM-1 (CD31) which is expressed on endothelial cells, monocytes and 
lymphocytes (188,189) were seen within lymph node cultures. Using principle 
component analysis (PCA) the samples could cluster based on the expression of these 
28 genes (figure 3.3b). The principle component analysis clearly demonstrates that the 
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liver, spleen and thymus stromal cell cultures cluster together whereas the lymph node 
stromal cell cultures form a more tightly clustered separate group. This suggests that it 
is possible to differentiate between stromal cells from the lymph node compared to the 
liver, spleen and thymus based on their gene expression. 
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Figure 3.3 Differential gene expression between lymphoid organs and lymph 
nodes  
(a) SAM analysis of Fibroblast LDA, dashed lines indicate the threshold of 
significantly different expressed genes using a 10% false discovery rate. Red dots = 
genes significantly upregulated in lymph nodes and green dots = genes significantly 
upregulated in lymphoid organs (b) PCA analysis based on the 28 significantly 
different expressed genes from the SAM analysis, red circles = lymphoid organs; 
spleen, liver and thymus and blue dots = lymph nodes; inguinal, axillary and cervical 
(n=3 independent stromal cell cultures for each tissue type). 
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Assay ID 
Gene 
Name Gene Name 
Mm00432086_m1 Blr1 Burkitt lymphoma receptor 1 
Mm00839967_g1 Ccl19 chemokine (C-C motif) ligand 19 
Mm00438260_s1 Ccr1 chemokine (C-C motif) receptor 1 
Mm00515543_s1 Ccr3 chemokine (C-C motif) receptor 3 
Mm00711660_m1 Cd80 CD80 antigen 
Mm00444543_m1 Cd86 CD86 antigen 
Mm00486906_m1 Cdh1 cadherin 1 
Mm00483888_m1 Col1a2 procollagen, type I, alpha 2 
Mm00457902_m1 Ctss cathepsin S 
Mm00438259_m1 Cxcr3 chemokine (C-X-C motif) receptor 3 
Mm00469294_m1 Ebi3 Epstein-Barr virus induced gene 3 
Mm00439616_m1 Il10 interleukin 10 
Mm00434151_m1 Il10ra interleukin 10 receptor, alpha 
Mm00434228_m1 Il1b interleukin 1 beta 
Mm00434295_m1 Il7r interleukin 7 receptor 
Mm00802901_m1 Lgals3 lectin, galactose binding, soluble 3 
Mm00442991_m1 Mmp9 matrix metalloproteinase 9 
Mm00443258_m1 Tnf tumor necrosis factor 
Mm00619239_m1 Tnfrsf14 
tumor necrosis factor receptor superfamily, member 14 
(herpesvirus entry mediator) 
Mm00446361_m1 Tnfrsf21 tumor necrosis factor receptor superfamily, member 21 
Mm00444567_m1 Tnfsf14 tumor necrosis factor (ligand) superfamily, member 14 
Mm00437154_m1 Tnfsf9 tumor necrosis factor (ligand) superfamily, member 9 
Mm00432087_m1 Bmp4 bone morphogenetic protein 4 
Mm00445212_m1 Kit kit oncogene 
Mm00476702_m1 Pecam1 platelet/endothelial cell adhesion molecule 1 
Mm00443242_m1 Tek endothelial-specific receptor tyrosine kinase 
Mm00446231_m1 Tgfa transforming growth factor alpha 
Mm00457866_m1 Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b 
 
Table 3.1 Fibroblast LDA differentially expressed genes 
Genes highlighted in red = genes significantly upregulated in lymphoid organs. Genes 
highlighted in turquoise = genes significantly upregulated in lymph nodes. 
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3.2.1.3 Fibroblast protein expression 
To characterise more fully the phenotype of the cells within the stromal cell cultures 
and establish if the gene expression data was indicative of the proteins expressed on 
the cell surface flow cytometry was used. Flow cytometry allows simultaneous 
multiparametric analysis of the physical and/or chemical characteristics of single live 
cells. VCAM-1 (150), gp38 (72), Vimentin (138) and CD248 (140) were selected as 
fibroblast markers; CD45 to indicate haematopoietic cells (189), F4/80 to indicate 
macrophages (190); CD11c to indicate dendritic cells (191) and CD31 for endothelial 
cells (188). Protein expression heterogeneity was seen within our cultured stromal 
cells (figure 3.4). Reassuringly, expression of CD248, VCAM-1 and gp38 was seen in 
all cultures, except in the cervical lymph node culture where VCAM-1 was not 
detectable. The expression of these fibroblast indicators confirms their presence 
within the stromal cell cultures. Low expression of F4/80 and CD11c was observed 
suggesting there are few macrophage and dendritic cells present. CD31 expression 
was seen only in the inguinal and axillary lymph node cultures suggesting that the 
predominant cell population could be lymphatic endothelium. Interestingly, CD45 
expression was present albeit at differing levels, in the spleen, thymus, liver and 
cervical lymph node cultures. The CD45 expression observed indicates that there are 
haematopoietic cells present in all cell cultures except those from inguinal and 
axillary lymph nodes. The presence of these other contaminating cell types could 
affect the aim of defining gene and protein expression differences between the stromal 
cell cultures.  
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Figure 3.4 Cell surface protein expression of cultured stromal cells from 
different lymphoid organs 
Flow cytometry data of cultured stromal cells at passage four obtained from different 
lymphoid organs of C57BL6 mice. Red = irrelevant control, black outline = positive 
protein staining (Plots representative of n=3 independent stromal cell cultures for each 
tissue type). 
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3.2.2 Homogeneous stromal cell cultures 
 
Having observed differences in gene and protein expression when comparing the in 
vitro stromal cells, there were concerns that these may be due to, or influenced by, the 
heterogeneity within the cell cultures. The primary concern being, the contaminating 
CD45 positive cells, which are not classically thought to be stromal. Although this 
population decreased over time, it was still present after twelve passages (data not 
shown). One solution was to sort the cell cultures based upon their CD45 expression, 
culturing CD45 negative cells only and therefore leading to a more homogenous cell 
population. 
 
3.2.2.1 Sorting stromal cell cultures 
Sorting of the stromal cell cultures was originally attempted straight ex vivo, however 
the number of CD45 negative cells was very low, typically with poor survival in 
culture. Therefore, stromal cells were cultured without selection (section 3.2.1) until 
at least passage five and then sorted based on CD45 expression. Figure 3.5 shows a 
representative sort where two populations were collected; CD45 negative and positive 
cells. Both fractions were transferred back into culture to achieve a more 
homogeneous population. The typical purity for cell sorts was above 98%. 
 
The CD45 negative sorted cells survived well in culture and continued proliferating 
up to at least 35 passages in vitro (data not shown). However, the CD45 positive cells 
grew poorly and when analysed by flow cytometry it appeared that the contaminating 
1-2% of CD45 negative cells out competed the CD45 positive cells (data not shown). 
Thus, in all subsequent experiments CD45 negative sorted stromal cells were used. 
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Figure 3.5 Stromal cell sorting based on CD45 expression  
A forward scatter (FS) and side scatter (SS) gate was set for cell size, with a FS and  
pulse width gate set to ensure doublets were excluded. Finally two gates were set to 
acquire the positive and negative CD45 protein expressing populations. The gates 
shown are those typically used, with the usual percentage purities obtained. 
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3.2.2.2 Flow cytometry analysis of sorted stromal cell cultures 
To determine the homogeneity of the sorted CD45 negative populations, the panel of 
surface protein markers used on the unsorted cell cultures (figure 3.4) was repeated on 
the cultures at passage 4/5 post sorting (figure 3.6).  
 
Importantly, it was observed that the sorted CD45 negative stromal cells maintain 
their CD45 negative expression phenotype. In addition, in comparison to the unsorted 
cells there was a more homogeneous phenotype across all stromal cell cultures; there 
was no F4/80 expression with concomitant high expression of VCAM-1, CD248 and 
gp38. Interestingly, the low CD31 expression observed only in the inguinal and 
axillary lymph node stromal cell cultures still remained post sorting. This indicates 
that these stromal cell cultures have an endothelial-like phenotype. CD11c expression 
was not assessed as this expression was very low in the unsorted cultures, however 
inter-cellular adhesion molecule 1 (ICAM-1) was added to the panel as current 
literature states its importance in stromal cell interactions with other cell types (35). 
ICAM-1 is differentially expressed amongst the stromal cell cultures, with spleen, 
liver and inguinal lymph node stromal cell cultures contain ICAM-1 positive cells 
whereas the thymus, axillary and cervical lymph nodes do not. At this juncture CD45 
negative sorted stromal cell cultures from peripheral sites such as lung and skin were 
also included. This is a significant comparison to include as previous work in humans 
has shown that fibroblasts from peripheral sites can be grouped separately to those 
from lymphoid sites using gene expression analysis (150). Whether this is mirrored in 
the murine system is an important point to clarify. In addition to the lymphoid organ 
stromal cell cultures, the lung and skin stromal cell cultures also maintained their 
CD45 negative phenotype. They did not express F4/80 or CD31 and had high 
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expression of VCAM-1, CD248 and gp38. The lung stromal cell cultures expressed 
ICAM-1 whereas the skin stromal cells did not.  
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Figure 3.6 Cell surface protein expression of cultured CD45 negative stromal 
cells from lymphoid and peripheral organs  
Flow cytometry data of cultured CD45 negative sorted stromal cells at passage 4/5 
post sort, from lymphoid and peripheral organs of C57BL6 mice. Red = irrelevant 
control, black outline = positive protein staining (Plots representative of n=3 stromal 
cell cultures for each tissue type). 
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3.2.2.3 Immunofluorescent analysis of sorted stromal cell cultures 
As a complimentary method to flow cytometry, immunofluorescence was used to 
examine the cell surface proteins present on the cultured stromal cells. As with flow 
cytometry, it can determine both the presence and relative quantity of a specific 
protein but also has the added benefit of revealing the location of the protein within a 
cell population. Protein heterogeneity was observed within cultured CD45 negative 
stromal cell populations (figure 3.7 – 3.9). Importantly, no CD45, F4/80 or CD11c 
positive staining was observed (data not shown). This suggests that not only do the 
sorted stromal cell cultures maintain their CD45 negative phenotype but also that 
sorting provides a more homogeneous cell culture with no haematopoietic, dendritic 
or macrophage cell contamination, confirming the flow cytometry data. Again 
consistent with the flow cytometry data all cultures expressed the stromal markers 
gp38 and CD248. Interestingly, both single and double positive populations were 
present in all cultures although to differing extents. In contrast however, VCAM-1 
expression differed from that observed by flow cytometry, with only very low levels 
observed in the liver (figure 3.7c), cervical lymph node (figure 3.8c) and skin (figure 
3.9b) stromal cell cultures. Co-expression of gp38 and VCAM-1 was observed in the 
spleen (figure 3.7a), thymus (figure 3.7b) and inguinal lymph node (figure 3.8a) 
stromal cell cultures with co-expression of CD248, VCAM-1 and gp38 only observed 
in spleen (figure 3.7a) and axillary lymph node (figure 3.8b) stromal cell cultures. In 
all stromal cell cultures, where seen, CD248, gp38 and VCAM-1 protein expression 
was observed uniformly on the cell surface with no nuclear staining apparent. Taken 
together these data demonstrate that there are phenotypic differences between stromal 
cell cultures from distinct sites. Although more homogeneous, immunofluorescence 
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highlights that the stromal populations present still differ within each culture, even 
when looking at only three stromal markers. 
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Figure 3.7 Immunofluorescence staining of CD45 negative sorted stromal cells 
Stromal cells fixed in acetone (passage 10) (a) spleen (b) thymus (c) liver, were co-
stained for surface proteins CD248 (blue), gp38 (red) and VCAM-1 (green) and cell 
nuclei (grey) and viewed at a magnification of x40. Differences between the cell 
cultures can be observed (n=2). 
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Figure 3.8 Immunofluorescence staining of CD45 negative sorted lymph node 
stromal cells  
Stromal cells fixed in acetone (passage 10) (a) inguinal (b) axillary (c) cervical, were 
co-stained for surface proteins CD248 (blue), gp38 (red) and VCAM-1 (green) and 
cell nuclei (grey) and viewed at a magnification of x40.  Differences between the cell 
cultures can be observed (n=2). 
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Figure 3.9 Immunofluorescence staining of CD45 negative sorted peripheral 
stromal cells  
Stromal cells fixed in acetone (passage 10) (a) lung (b) skin, were co-stained for 
surface proteins CD248 (blue), gp38 (red) and VCAM-1 (green) and cell nuclei (grey) 
and viewed at a magnification of x40.  Differences between the cell cultures can be 
observed (n=2). 
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3.2.2.4 Whole genome array analysis of sorted stromal cells 
Having observed heterogeneity between cultures derived from different sites based on 
protein expression, the gene expression profiles of each culture were next analysed to 
determine whether they could be grouped anatomically analogous to the human 
studies (151). RNA was extracted from all stromal cell lines, reverse transcribed and 
CyDye labelled with approximately 100pmols of labelled cDNA hybridised onto 
whole mouse genome arrays (section 2.7). The arrays contained 37,632 genes and 
were used as an unbiased approach to determine if a specific lymphoid organ 
fibroblast gene signature could be established (appendix 8.3). 
 
As with the Fibroblast LDAs, SAM analysis was used to determine the gene 
expression that differed significantly between the cultures (section 2.7.3). Using a 
0.03% false discovery rate (FDR), 2935 genes were found to be significantly different 
between peripheral and lymphoid stromal cell cultures (appendix 8.4). Normally the 
FDR is set to 10% during SAM analysis, however this gave a gene list that was too 
large to further analyse and therefore the FDR was decreased to 0.03%, which gave a 
workable number of genes. A hierarchical cluster, produced by the Institute of 
Genomic Research multi-experiment viewer (TMEV), of all samples using the 2935 
genes, showed peripheral stromal cell cultures, skin and lung, to be more similar to 
each other than to the lymphoid organ stromal cell cultures (figure 3.10a). PCA was 
used to cluster the samples based on the expression of the 2935 genes (figure 3.10b). 
This observation agrees with that found in human studies where whole genome 
expression grouped peripheral and lymphoid fibroblasts separately (150). When using 
this approach within the lymphoid stromal cell cultures alone, significant site specific 
gene expression was unable to group the samples into the lymphoid organ from which 
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they were obtained. To assess the biological significance of the 2935 genes found to 
be differentially expressed between peripheral and lymphoid stromal cell cultures, a 
database for annotation, visualisation and integrated discovery (DAVID) 
(david.abcc.ncifcrf.gov/tools.jsp) was used to determine pathways in which the genes 
were involved. Prior to DAVID analysis the 2935 genes were re-clustered in TMEV. 
This clusters the genes into groups based on similar expression patterns, from which 
individual clusters can be annotated (figure 3.11a). Each individual gene cluster was 
then put into DAVID and functional annotation clustering performed. From the list of 
pathways produced, those with a fold enrichment over two and a FDR of less than 
10% were selected, this is an accepted cut off to analyse significant changes (figure 
3.11b). These interestingly included a cluster of genes that were upregulated in the 
peripheral tissues when compared to lymphoid tissues which are involved in the 
innate immune response (section 3.3). 
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Figure 3.10 Whole mouse genome array analysis of CD45 negative sorted 
stromal cell gene expression 
Total RNA from CD45 negative sorted stromal cells was extracted, reverse 
transcribed, CyDye labelled and hybridised onto a whole mouse genome microarray 
of 37,632 genes (a) Hierarchical cluster analysis of samples revealed that peripheral 
CD45 negative stromal cells were more similar to each other than to the lymphoid 
CD45 negative stromal cells. Red = low, green = high and black = medium gene 
expression. (b) PCA of the 2935 genes differentially expressed within the stromal cell 
cultures. Pink circles = peripheral sites; skin and lung and turquoise circles = 
lymphoid sites; spleen, thymus, liver and inguinal, axillary and cervical lymph nodes 
(n=3 independent stromal cell cultures for each tissue type). 
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Figure 3.11 DAVID pathway analysis of 2935 genes differentially expressed 
between peripheral and lymphoid stromal cells 
Significant genes from SAM analysis of whole genome microarrays were (a) 
Hierarchically clustered into groups of similar gene expression patterns A-J. Red = 
low, green = high and black = medium gene expression. (b) Pathways over two fold 
enriched with a FDR <10% are shown. 
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As well as comparing the CD45 negative cultured stromal cells, immortalised spleen, 
thymus and mesenteric and peripheral lymph node stromal cell lines derived from 
clones and ex vivo splenic stromal cells sorted on gp38 and CD31 expression were 
also analysed using the whole mouse genome arrays. These were prepared and used 
with the permission of Dr Tobias Vogt and Dr Mirjam Britchgi, University of 
Lausanne, Switzerland. The purpose of this comparison was to determine the 
differential gene expression between in vivo, in vitro and immortalised cells. PCA of 
all 99 samples shows a clear separation of the ex vivo sorted cells from the in vitro 
cultured and immortalised cells lines (figure 3.12). Due to the large sample size SAM 
analysis could not be performed to determine the gene expression that differed 
significantly between all the samples. Therefore, SAM analysis was performed only 
on immortalised lymph node cell lines and the in vitro CD45 negative cultured lymph 
node cultures. Following analysis, 261 genes were found to be expressed 
differentially, with a FDR of 10%, between the five groups (appendix 8.5). 
Hierarchical clustering using these genes demonstrates that the immortalised cell lines 
group together, as do the in vitro cultured cells (figure 3.13a). PCA of these samples 
using the 261 genes shows not only a clear separation of immortalised cells lines and 
in vitro cultured cells but also separation within these groups based on the precise 
lymph node from which the cells were obtained, although the inguinal and axillary 
lymph node stromal cells were less tightly clustered (figure 3.13b). These genes were 
then clustered in TMEV and their grouped genes annotated for use in DAVID (figure 
3.14a). Pathways with a fold enrichment over two and a FDR of less than 10% were 
selected (figure 3.14b). Interestingly, five of the eight pathways that were different 
between the immortalised and the CD45 negative cultured lymph node stromal cells 
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were related to apoptosis (section 3.3). These were increased in the CD45 negative 
cultured cells compared with the immortalised cells. 
Chapter Three Results 96 
 
Figure 3.12 PCA of the in vitro cultured cells, immortalised cell lines and ex vivo 
sorted cells  
Total RNA from all cells was extracted, reverse transcribed, CyDye labelled and 
hybridised onto a whole mouse genome microarray. PCA grouped immortalised cell 
lines from p19
-/-
 peripheral lymph nodes and p53
-/-
 spleen, thymus and peripheral and 
mesenteric lymph nodes (red) with in vitro cultured stromal cells from spleen, 
thymus, liver, skin, lung and inguinal, axillary and cervical lymph nodes (blue), with 
ex vivo CD45
-
 and CD35
-
 stromal cells from peripheral lymph nodes noticeably 
separate (green). 
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Figure 3.13 Whole mouse genome array analysis of in vitro cultured CD45 
negative lymph node stromal cell cultures and immortalised lymph node stromal 
cell lines 
Total RNA from in vitro cultured CD45 negative lymph node stromal cells and 
immortalised lymph node stromal cell lines was extracted, reverse transcribed, CyDye 
labelled and hybridised onto a whole mouse genome microarray. (a) Hierarchical 
cluster analysis of samples grouped stromal cells from immortalised cell lines 
separately to those from in vitro cultured cells. Red = low, green = high and black = 
medium gene expression. (b) PCA analysis of the 261 differentially expressed genes. 
Red = cervical, blue = axillary, yellow = inguinal, green = immortalised peripheral 
and pink = immortalised mesenteric lymph node stromal cells. 
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Figure 3.14 DAVID pathway analysis of 261 genes differentially expressed 
between in vitro cultured and immortalised lymph node stromal cells 
Significant genes from SAM analysis of whole genome microarrays were (a) 
hierarchically clustered into groups of similar gene expression patterns A-G. The top 
six samples are in vitro cultured lymph node stromal cells and the bottom twenty four 
are immortalised stromal cells from peripheral or mesenteric lymph nodes. Red = low, 
green = high and black = medium gene expression. (b) Pathways over two fold 
enriched with a FDR <10% are shown. 
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3.2.2.5 End point PCR 
End point PCR was used to validate microarray results by determining the expression 
of a number of genes thought to be highly expressed for example CCL7, CCL19. 
CCL21, CXCL12, IL-7, LTβR, TNFR1, TRANCE. In addition, to validate the 
presence of fibroblasts expression of genes such as CD248, gp38, ICAM-1 and 
VCAM-1 were also determined. The end point PCR was analysed by running the 
products on a 1% agarose gel with molecular weight markers to determine their size 
(section 2.5.2) (figure 3.15). All stromal cell cultures showed expression of CCL7, 
CCL19, CCL21, CD248, CXCL1, CXCL12, gp38, ICAM-1, IL-7, IL-17RA, LTβR, 
PDGFRα, PDGFRβ, TNFR1, TRANCE, VEGFa, VEGFc and VCAM-1, which is 
consistent with the gene expression observed in the whole genome microarrays. Many 
of the genes expressed throughout the stromal cell cultures are stromal organiser cell 
markers, VCAM-1, ICAM-1, LTβR, TRANCE, CCL19 and CCL21 (35). 
Interestingly CXCL13, which is thought to be produced by stromal organiser cells, 
was only expressed in stromal cell cultures from the inguinal lymph node, skin and 
lung. In addition expression of other stromal markers gp38, CD248, PDGFRα, 
PDGFRβ and TNFR1 was consistently seen. However differential gene expression 
between the stromal cell cultures was also observed, the lymphatic endothelial 
markers CD31 and Lyve-1 were expressed in the cervical and axillary lymph node 
and the skin and lung stromal cell cultures but not in the others. EpCAM was not 
expressed in any of the cell cultures. The differential expression observed between 
stromal cell cultures was not mirrored by the pattern of expression seen using the 
microarrays. However, expression of EpCAM was very low in all stromal cell 
cultures using microarray analysis.  The gene expression observed by end point PCR 
of CD248, gp38 and VCAM-1 correlated with protein expression observed by flow 
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cytometry in the stromal cell lines (section 3.2.2.2). However, ICAM-1 gene 
expression was seen in all stromal cell cultures by end point PCR whereas ICAM-1 
protein expression was only seen in the spleen, liver, inguinal lymph node and lung 
stromal cells. This differential expression between transcript and protein may be due 
to the lack of translation of that gene in particular cell lines. 
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Figure 3.15 End point PCR results of selected genes from CD45 negative sorted 
stromal cells  
RNA from CD45 negative sorted stromal cell cultures, was reverse transcribed and 
end point PCR performed S=Spleen, T=Thymus, L=Liver, I=Inguinal lymph node, 
A=Axillary lymph node, C=Cervical lymph node, Sk=Skin and Lu=Lung. (n=2). 
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3.2.2.6 Site Specific TaqMan LDA 
The whole mouse genome microarrays were used as an unbiased approach to 
determine if a specific lymphoid organ fibroblast gene signature could be established. 
From these it was possible to separate cultured stromal cells from peripheral and 
lymphoid tissues but not those within the lymphoid tissue group. Therefore, a 
TaqMan LDA was designed based on the 337 genes found to be human fibroblast site 
specific as previously described by Rinn et al, 2006. The site specific LDA contained 
47 of the genes found to important in defining human fibroblast site specificity, 
covering a broad range of families (appendix 8.6). To analyse gene expression data 
from each of the stromal cell cultures, RNA was extracted and approximately 1µg was 
hybridised to the LDA. Following real-time PCR all data was normalised to the 
expression of housekeeping gene 18S (appendix 8.7). Hox gene expression was 
analysed first given their reported importance in the literature (151,152) (figure 
3.16a). Similar high gene expression levels were seen of Hoxa5 with very low gene 
expression of Hoxa13 across all stromal cell cultures. Hoxb2 expression was 
decreased in the skin stromal cell cultures with Hoxa11 noticeably decreased in lung 
stromal cells and to a lesser extent in the thymus. Hoxd8 showed the greatest variation 
between the stromal cell cultures, very high expression was seen in all lymph node 
stromal cell cultures, with a decrease in spleen, thymus and liver and to a greater 
extent in the skin and lung stromal cell cultures. From the 47 genes on the low density 
array 15 non-Hox genes were observed to have differential expression between the 
stromal cell cultures (figure 3.16b). CD31 and Lyve-1 were highly expressed in the 
inguinal, axillary and cervical lymph node stromal cell cultures compared to all other 
stromal cell cultures, mirroring that seen in the whole mouse genome arrays (section 
3.2.2.4). In addition, CD248, Wisp2, Fxf1a, Gulp, Fn, Adam9, Col11a1, Plat and 
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Bmp4 gene expression was lower in the skin and lung stromal cell cultures than the 
lymphoid stromal cell cultures. A decrease in expression of Wisp2 was also observed 
in the liver stromal cell cultures and a decrease in Plat expression in the splenic 
stromal cell cultures. In addition, CXCL1 was increased in the cervical lymph node 
stromal cell cultures alone and Grem2 expression was increased in the cervical lymph 
node, skin and lung stromal cell cultures. Grem2 is thought to play a role in regulating 
organogenesis, body patterning, and tissue differentiation (192). Moreover, this low 
density array also demonstrated some differences in gene expression between all the 
stromal cell cultures with Cdh1 and Mmp3 having variable expression. Cdh1 is the 
gene for the cell adhesion protein epithelial-cadherin (193) and Mmp3 is an enzyme 
involved in the breakdown of extracellular matrix (194). The site specific LDA 
highlights again the gene expression differences between lymphoid and peripheral 
stromal cell cultures. In addition, it reveals genes, Grem2, Cdh1 and Mmp3, that are 
differentially expressed between all the stromal cells cultures.  
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Figure 3.16 Gene expression of CD45 negative stromal cells on site specific LDA 
Gene expression from stromal cell cultures was determined using a site specific 
designed TaqMan LDA (a) Hox gene expression (b) differentially expressed genes 
(n=3 independent stromal cell cultures for each tissue type). 
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3.3 Discussion 
The aim of this chapter was to characterise fibroblasts from different sites within the 
mouse; gene and protein expression was assessed to achieve this.  
 
Importantly from this chapter an efficient protocol for the growth of stromal cells 
from mouse lymphoid tissues, which can be reliably used for future functional studies, 
has been derived. In the literature the most favourable culture conditions for growing 
human and mouse fibroblasts are stated as 10% FCS in Dulbecco‟s Modified Eagles 
Medium (167,195,196). This method is now part of our standard operating procedure 
(SOP) for mouse fibroblast cell culture. For experimental work, fibroblasts have 
previously been described to be used at between passage five (151) and passage ten 
(119). We found that above passage five was an optimum passage number for use 
with the cell sorter and after sorting cells have maintained their phenotype above 
passage 35 so far.  
 
Although a specific marker has not yet been found for fibroblasts, there are several 
markers that can be used, however none are exclusive (138,197). For these reasons a 
panel of fibroblast indicators were used on the stromal cell populations acquired by 
enzymatic digestion from the spleen, thymus, liver, skin, lung and inguinal, axillary 
and cervical lymph nodes. This included VCAM-1 (150), CD248 (140) and gp38 (72) 
along with classic markers of other cell types, including haematopoietic cells (CD45) 
(189), macrophages (F4/80) (190), dendritic cells (CD11c) (191) and endothelial cells 
(CD31) (188), to exclude non-fibroblast-like cells. Parsonage et al (2003), observed 
morphological, mRNA and protein expression differences when growing human 
fibroblasts in culture (150). This correlates with the differential gene and protein 
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expression seen in cultured stromal cells (section 3.2); following FACS analysis 
CD248, gp38 and VCAM-1 protein expression was observed in all cultures. 
Moreover, genes such as vimentin and the pro-collagens were shown to be highly 
transcribed in the Fibroblast LDA (figure 3.3). Taken together these data suggest that 
fibroblasts are present in the cultures. However, protein expression of markers for 
other cell types including haematopoietic cells (CD45), dendritic cells (CD11c), 
endothelial cells (CD31) and macrophages (F4/80) was also seen. From the Fibroblast 
LDA, it became clear that other cell populations were present in the cell cultures. 
SAM analysis gave gene expression that differed significantly between cultures. For 
example CD80 and CD86 were increased in spleen, liver and thymus stromal cultures, 
suggesting the presence of antigen presenting cells. CD80 is expressed on activated B 
cells and monocytes (185). CD86 provides co-stimulatory signals for T cell activation 
and survival (186). CD117 (KIT), a molecule expressed on the surface of 
haematopoietic stem cells showed high expression on lymph node stromal cell 
populations (187). Furthermore high CD31 expression was observed in lymph node 
stromal cell populations, which indicates the presence of endothelial cells (188). The 
conclusion from the flow cytometry and Fibroblast LDA data was that the in vitro 
cultures were heterogeneous and included cell types other than the fibroblast. 
 
To address the concerns about the heterogeneity of the cultures, the stromal cells were 
sorted on CD45 expression (section 3.2.2.1), with CD45 negative stromal cells grown 
successfully to obtain a more homogenous population. Upon analysis of gene and 
protein expression of these CD45 negative sorted cells (section 3.2.2.4 and 
3.2.2.2/3.2.2.3 respectively) differences in gene and protein expression between the 
cell cultures was still observed, which was not due to contaminating CD45 positive 
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cells. It was at this stage that peripheral sites, lung and skin, were included. It has 
been shown previously within humans that fibroblasts can be grouped into peripheral 
and lymphoid sites using whole genome microarray analysis (150). This is an 
important finding to address within the murine studies and was intended to be used as 
a positive control in addition to the groupings within the lymphoid tissues. The 
protein expression of the CD45 negative sorted cells (section 3.2.2.2) assessed by 
flow cytometry showed a more homogeneous population, with no F4/80 expression 
and high levels of VCAM-1, CD248 and gp38 in all stromal cell cultures. High 
expression of CD248 and gp38 was also seen by immunofluorescence (section 
3.2.2.3), along with an elongated, spindle shaped morphology which is associated 
with fibroblasts. The single positive CD248 or gp38 stromal cells observed may due 
to their stage in the cell cycle, as by flow cytometry all cells expressed both markers. 
Interestingly, VCAM-1 expression was variable when analysed by 
immunofluorescence where it was highest in spleen, with lower expression detected in 
all but the cervical lymph node stromal cell cultures where none was detected. 
However, VCAM-1 gene expression was found to be high in gene arrays and end 
point PCR so there may have been technical issues with the immunofluorescent 
staining. This could be due to the treatment of the cells prior to staining, cells are 
fixed before immunofluorescent staining, which could have affected the VCAM-1 
protein expression or available epitope required. Whereas, for flow cytometry, cell 
dissociation buffer is used, which may preferentially release VCAM-1 high 
populations of stromal cells. Finally, when immunofluorescence was performed triple 
staining of CD248/gp38/VCAM-1 was used whereas for flow cytometry single colour 
staining was performed for each marker. It is possible that the fluorescence of the 
other antibodies affected that of the VCAM-1. Ultimately the sensitivity of the 
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techniques could explain the differences seen, if there is only a small amount of 
VCAM-1 present a more sensitive technique would highlight it. The dysregulation 
between mRNA and protein expression is often seen and probably due to the high 
sensitivity of PCR and post-transcriptional control.  In the inguinal and axillary lymph 
node stromal cell cultures there was a very low amount of CD31 expression observed 
by flow cytometry, indicating these cells may have a more endothelial-like phenotype. 
This was confirmed by the whole genome microarrays and the site specific LDA 
where expression of CD31 and lymphatic endothelial marker Lyve-1 was observed 
(section 3.2.2.4 and 3.2.2.6). One consistent difference between the stromal cell 
cultures was protein expression of ICAM-1, expression was seen in spleen, liver, lung 
and inguinal lymph node cultures. Studies by Cupedo et al (45) and Okuda et al (198) 
have highlighted distinct populations of stromal organiser cells within peripheral and 
mesenteric lymph nodes, that have intermediate or high levels of ICAM-1 and 
VCAM-1. Whilst both lymph nodes contained the different populations, they were 
present in different numbers and ratios. The genes differentially expressed in these 
populations included VCAM-1, ICAM-1, CXCL13, CCL21 and CCL19. This may 
demonstrate the varied microenvironment present in these lymph nodes and provides 
evidence as to why they have diverse developmental requirements (section 1.2.1.4). 
The ICAM-1 expression variation seen in the stromal cell cultures may be indicative 
of the dominant stromal organiser population present in the spleen, liver, lung and 
inguinal lymph node cultures.  
 
Following protein expression analysis, whole genome microarrays were used to 
determine if a specific lymphoid organ fibroblast gene signature could be established.  
The gene expression observed was able to group the stromal cell cultures into 
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peripheral and lymphoid sites with expression of 2935 genes being statistically 
different (figure 3.10). In order to ascertain the biological relevance from this large 
amount of genes, analysis in the programme DAVID was completed. This produced 
16 pathways that had over a two fold enrichment with an FDR of less than 10%. The 
pathways that were enriched in the peripheral stromal cell cultures were involved in 
metabolic processes and lipid biosynthesis. Metabolism is a collective term for 
catabolism, where complex molecules are broken down and anabolism, where 
complex molecules are made. Cell substrate pathways were also enriched in 
peripheral cultures over five fold. This may indicate that stromal cells from the 
peripheral organs have a more active phenotype as there is an increase in the synthesis 
and degradation of molecules. Interestingly pathways involved in the innate immune 
response were over four fold enriched in peripheral stromal cell cultures. This is to be 
expected as peripheral tissues are the first to come into contact with foreign antigen, 
where the innate immune response is the first defence (1). The lymphoid tissues are 
mainly involved in the adaptive immune response which is specific to the antigen (2). 
In the lymphoid tissues pathways involved in cell division, RNA and mRNA 
processing and splicing, DNA packaging and chromatin organisation, biogenesis and 
architecture are enriched. This may suggest an increased rate of cell division and 
translation in the lymphoid stromal cell cultures and all elements that are associated 
with this process. In immune responses secondary lymphoid organs are continually 
expanding and contracting as the cell numbers increase and decrease in response to 
pathogens. This may explain why these pathways are upregulated in the stromal cells 
of these tissues as appose to those from peripheral sites. During gene expression 
analysis of the cultured CD45 negative stromal cells, they were also compared to 
immortalised stromal cell lines and ex vivo sorted stromal cells (figure 3.12) Here 
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principle component analysis found that the in vitro cultured CD45 negative stromal 
cells were more similar to immortalised stromal cell lines than ex vivo sorted stromal 
cells. This raises the issue of in vitro cell culture affecting the phenotype of cells. It 
remains good practice to use the stromal cell cultures at a low passage, therefore 
minimising the potential differences imposed by culturing the cells (167,199). 
Contrary to this however, in vitro studies have shown that continual passaging up to 
passage 35 did not effect gene expression in human fibroblasts when assessed by 
whole genome arrays (152). To further analyse the similarity between the 
immortalised cell lines and the in vitro cultured cells, gene expression from all lymph 
node stromal cell cultures from both groups were compared (figure 3.13). From SAM 
analysis, expression of 261 genes was determined to be statistically different. Again 
these were analysed using DAVID to assess their biological relevance. Five out of the 
eight pathways enriched in the in vitro cultured CD45 negative stromal cells that had 
over a two fold enrichment with an FDR less than 10%, were apoptosis and cell death 
related. This may be due to immortalised cell lines having altered growth properties, 
allowing them to grow and divide indefinitely in vitro given the correct culture 
conditions, which may decrease their rate of apoptosis (200). Pathways in cell 
development were also enriched by over 9-fold in the in vitro cultured lymph node 
stromal cells. These are involved in formation of the mature cell structure and 
terminal differentiation. As the in vitro grown stromal cells have been in long term 
culture, it may be that they have a finite life span and therefore express features of an 
aged cell.  
 
End point PCR was used to validate the microarray gene expression (figure 3.15) 
Fibroblast indicator genes such as VCAM-1, gp38 and CD248 were shown to be 
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expressed in all stromal cell cultures, which correlates with microarray and protein 
expression data. Gene expression indicative of lymphoid tissue organiser (LTo) cells 
(figure 1.4) LTβR, TRANCE, VCAM-1, ICAM-1, CCL19 and CCL21 was also 
shown. LTo cells are believed to develop from mesenchymal cells and are important 
in the formation of lymph nodes, where they interact with lymphoid tissue inducer 
(LTi) cells (section 1.2.1.3). The stromal cell cultures all have the phenotype of LTo 
cells, it may be that the stromal cells from non-lymphoid organs have the potential to 
function as LTo cells given their gene expression. Under the correct conditions, for 
example chronic inflammation, they may play a role in tertiary lymphoid tissue 
formation by functioning as LTo cells. In contrast, expression of CD31 and Lyve-1 is 
present at varying levels in the lymph node stromal cell cultures, the highest in 
cervical and axillary lymph node stromal cell cultures. The microarray data showed 
high levels of both markers in all of the lymph node stromal cell cultures. This 
indicates that the lymph node stromal cultures may in fact be lymphatic endothelial-
like stromal cells. The end point PCR gene expression correlated with those genes 
seen expressed in all stromal cell cultures. However it did not correlate with those 
shown to be differentially expressed. One explanation for this difference seen between 
techniques could be the sensitivity of the microarrays. End point PCR provides a 
positive or negative result whereas the microarray shows quantitative expression, 
providing information on the extent of the gene expression. 
 
As the CD45 negative lymphoid cultures were unable to be separated using the whole 
genome arrays, a site specific LDA was used to determine expression of 47 genes 
indicated by Rinn et al who found that primary adult fibroblasts retained many 
features of the embryonic pattern of expression of Hox genes (151). This profile was 
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maintained over decades in vivo and up to at least passage 35 in vitro, suggesting that 
Hox gene expression is an important source of positional memory (152). Hox genes 
are a sub group of homeobox genes, in vertebrates these are found in clusters on 
chromosomes. In mammals four clusters exist, named Hoxa-d. The site specific LDA 
assessed the gene expression of five Hox genes, namely Hoxa13, Hoxb2, Hoxa11, 
Hoxd8 and Hoxa5, 4 of which were expressed by our stromal cell cultures with 
Hoxa13 expression below the threshold level. Hoxa13 is a distal specific Hox gene 
and disruption leads to hand-foot-genital syndrome in humans (201). Lack of 
expression in the stromal cell cultures was therefore expected as none were derived 
from distal organs. Hoxa5, thought to regulate the tumour suppressor p53 in humans 
(202), had a fairly consistent expression, as did Hoxb2, which functions as a 
transcription factor involved in development (203), though there was a slight decrease 
in skin stromal cell cultures. Hoxa11 was expressed in all but the lung stromal cell 
cultures, which in humans is involved in uterine development and is required for 
female fertility (204). Hoxd8 showed the greatest variation, with high expression in 
the lymph nodes, lower in the spleen, liver and thymus and a further decrease in the 
skin and lung stromal cell cultures. The pattern of Hoxd8 expression could be used to 
determine if a fibroblast was isolated from a peripheral site or a lymph node as there 
is over a 10 fold increase in axillary and cervical lymph node derived stromal cells. 
Loss of the Hoxd gene cluster results in severe limb and genital abnormalities, with 
Hoxd8 specifically thought to be involved in adult urinary tract function (205). The 
data here however may suggest it could also be involved in lymph node stromal cell 
patterning. Other genes assessed by the site specific LDA showed differential 
expression among sites (figure 3.16b). CD31 and Lyve-1 expression was increased in 
the lymph node stromal cell cultures, most notably in the Lyve-1 expression, 
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indicating a lymphatic endothelium genotype as observed with the end point PCR and 
microarray data. Interestingly, Grem2 which was not observed in the spleen stromal 
cells, expressed at low levels in the inguinal lymph node stromal cells, at intermediate 
levels in the thymus, liver and axillary stromal cells and high levels in the cervical 
lymph node, lung and skin stromal cells, is thought to play a role in regulating 
organogenesis, body patterning and tissue differentiation (206). This may indicate a 
novel role in fibroblast regional specificity. Cdh1 and Mmp3 are also differentially 
expressed between sites. Cdh1 encodes a cell-cell adhesion protein and has a tumour 
suppressor function (207) and Mmp3 is an enzyme involved in the breakdown of 
extracellular matrix (194). The differential expression of these genes may represent 
the specific needs of the microenvironment of that stromal cell population. CD248, 
Wisp2, FoxF1a, Gulp, Adam9, Fn, Colla1, Bmp4 and Plat all had a lower expression 
in the peripheral stromal cell cultures compared to lymphoid stromal cell cultures. 
Again this could be due to the requirements of a specific microenvironment, with 
peripheral fibroblasts having different extracellular matrix components and supports 
the differences observed between lymphoid and peripheral stromal cell cultures using 
whole genome microarrays. 
 
In conclusion, these data highlight major differences between unsorted lymph node 
stromal cell cultures and those from the spleen, thymus and liver. In CD45 negative 
sorted cultures a gene signature of lymphoid tissue stromal cells was determined that 
was different to that from peripheral tissue stromal cells. However this could not 
differentiate between lymphoid tissue stromal cells. Further studies using LDA 
showed that Hoxd8, Grem2, Cdh1 and Mmp3 may be used to differentiate between 
lymphoid tissue stromal cells, although protein expression has yet to be determined so 
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this data needs further investigation. Finally the gene expression observed indicates 
that the stromal cell cultures may have the expression profile of LTo cells. This 
finding needs to be further investigated using functional assays. 
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CHAPTER FOUR 
 
In vitro Function of Fibroblast Populations from Different Sites 
 
4.1 Introduction 
The cross talk between lymphoid tissue inducer (LTi) cells and lymphoid tissue 
organiser (LTo) cells has been shown to be critical to lymph node organogenesis (35) 
and involves the ligands and receptors of the tumour necrosis family (TNF) family 
(36). Lymphotoxin (LT) α, LTβ and TNF are structurally homologous cytokines 
grouped within the TNF ligand family (37). TNF and LTα can bind to TNF receptors 
TNFRI and TNFRII. However, LTβ forms a functional heterotrimeric complex, 
LTα1β2 to bind to its receptor, lymphotoxin β receptor (LTβR) (38,39). The 
importance of this interaction in functional secondary lymphoid organ formation has 
been demonstrated by LTα knockout mice. In these mice all lymph nodes and Peyer‟s 
patches are absent, with the spleen and nasal-associated lymphoid tissue (NALT) 
being highly disorganised (40). LTα has been shown to be a key factor in the 
differentiation of stromal cells into stromal organiser cells, recognised by the 
upregulated expression of several surface proteins including VCAM-1 and ICAM-1 
(35). In this study the gene expression, for example LTβR, TRANCE, VCAM-1, 
ICAM-1, CCL19 and CCL21, of all the stromal cell cultures is indicative of LTo 
cells. Therefore the stromal cells were treated with LTα to determine if their 
functional response was also suggestive of an LTo phenotype.  
 
Another function of the LTo is their interaction with lymphocytes. Previous work has 
shown that stromal cells co-cultured with lymphocytes results in an increase in 
lymphocyte survival. This is thought to be mediated by survival factors produced 
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from the stromal cells and IL-7 was shown to be at least partly responsible for this 
enhanced survival (67). In this study the gene expression of known lymphocyte 
survival factors such as IL-6 (208), IL-7 (209,210) and CCL19 (67) were observed in 
the stromal cell cultures, therefore the co-culture of lymphocytes with cultured 
stromal cells from different mouse organs was assessed to determine if enhanced 
survival occurred and if this was affected by the origin of the stromal cell.  
 
In this chapter functional differences were seen between lymphoid and peripheral 
stromal cell populations in their response to LTα, and also within the lymphoid tissue 
stromal cells in terms of the degree of their response. Increased lymphocyte survival 
was observed in co-culture with all stromal cells, however B cells showed only a 
minimal enhancement of survival with the effect on T cell survival being much 
greater. 
 
4.2 Results 
4.2.1 LTα treatment of stromal cells 
Having noted that the phenotype of the stromal cell cultures was similar to that 
described in the literature as a lymphoid tissue organiser (LTo) cell, the function of 
these cells was analysed. As LTα has been shown to be a key factor in the 
differentiation of stromal cells into stromal organiser cells and in LTo interaction with 
LTi, its effect on the cultured stromal cells was determined. The effect of LTα on 
VCAM-1 and ICAM-1 expression in stromal cell cultures was assessed by treating 
splenic stromal cell cultures with LTα at a range of concentrations for 24 hours 
(figure 4.1a). LTα was shown to increase expression of both VCAM-1 and ICAM-1, 
with increasing concentrations of LTα also increasing protein expression. Although 
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2.5µg/ml of LTα increased VCAM-1 expression as compared to 1µg/ml, it did not 
warrant using a dose 2.5 times higher. ICAM-1 expression increased up to a LTα 
concentration of 1µg/ml but no further increase in expression was seen with 2.5µg/ml. 
Therefore, 1µg/ml of LTα was used during a time course to assess dynamics of 
VCAM-1 and ICAM-1 expression (figure 4.1b). LTα treatment increased ICAM-1 
expression up to 24 hours and then decreased by 72 hours. VCAM-1 expression was 
increased up to 12 hours after LTα treatment, where it remains high to 24 hours and 
then similar to ICAM-1 decreased by 72 hours. Therefore splenic stromal cells were 
treated with 1µg/ml of LTα for 24 hours as determined by the titration and time 
course (figure 4.1c). No effect was seen of LTα treatment on isotype control 
expression and a clear increase in VCAM-1 and ICAM-1 expression was observed. 
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Figure 4.1 LTα increases VCAM-1 and ICAM-1 expression in splenic stromal 
cells 
LTα treatment of splenic stromal cells. (a) Mean fluorescence intensity (MFI) of 
VCAM-1 (red) and ICAM-1 (black) protein expression assessed by flow cytometry 
following treatment with LTα for 24 hours (n=1). (b) Time course of treatment with 
1µg/ml LTα, data is expressed as a ratio of baseline MFI: MFI following treatment of 
VCAM-1 (red) and ICAM-1 (black) protein expression (n=1). (c) Effect of treatment 
with 1µg/ml LTα for 24 hours. Red = baseline isotype control, black outline = LTα 
treated isotype control, green outline = baseline protein expression and blue outline = 
LTα treated protein expression. Graphs are representative of 6 independent 
experiments. 
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Having observed that 1µg/ml LTα treated for 24 hours was required for maximal 
increase in VCAM-1 and ICAM-1 expression in splenic stromal cell cultures; this was 
repeated in all stromal cell lines (figure 4.2). A significant increase (p<0.05) in 
VCAM-1 expression in all but the skin stromal cell cultures was observed. ICAM-1 
protein expression was significantly (p<0.05) increased in the spleen, inguinal lymph 
node and lung stromal cell cultures. The thymus, skin and axillary and cervical lymph 
node stromal cell lines showed little or no increase. However, the corresponding 
untreated cells of these stromal cells lines also had very little or no ICAM-1 
expression. This pattern of ICAM-1 expression correlates with the protein expression 
assessed by flow cytometry (section 3.3.2.1). These data suggest that LTα can only 
increase ICAM-1 expression in cells that are already expressing the protein. The 
significant increase in VCAM-1 expression in all stromal cells but those derived from 
the skin and in ICAM-1 expression in the spleen, inguinal lymph node and lung 
stromal cells indicates that these stromal cells may have the ability to function as LTo 
cells.  
 
During development the function and phenotype of stromal cells differ (50). 
Therefore, having observed that LTα increases VCAM-1 and ICAM-1 expression in 
adult splenic stromal cell cultures, cultures derived from E15 and newborn spleens 
were analysed (figure 4.3). Not only was a difference in VCAM-1 and ICAM-1 
expression observed in cultures from different stages in development but also their 
response to LTα differed. Very little VCAM-1 expression was seen in E15 splenic 
stromal cells, with a stark increase in the newborn, which then decreased in the adult, 
although expression still remained high compared with the E15 cultures. Interestingly 
however, LTα induces a significant increase (p<0.05) in VCAM-1 expression only in 
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the adult derived cultures. Expression of VCAM-1 in newborn cultures does generally 
increase, however failed to reach significance. ICAM-1 expression followed the same 
trend as VCAM-1 in the untreated cells, in that ICAM-1 expression was increased in 
newborn cultures with concomitant decrease in adult cultures, however expression in 
the adult cultures was lower than in E15. Upon LTα treatment E15, newborn and 
adult splenic cultures significantly increased ICAM-1 expression (p<0.05, p<0.001, 
p<0.05 respectively). 
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Figure 4.2 Effect of LTα expression on VCAM-1 and ICAM-1 expression on 
stromal cells 
Stromal cells were treated with 1µg/ml LTα for 24 hours, after which (a) VCAM-1 
and (b) ICAM-1 expression was determined by flow cytometry. Purple = untreated 
and black = treated cells, dots represent individual experiments and bars represent the 
median (n=6). *, p<0.05. 
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Figure 4.3 Effect of LTα treatment on VCAM-1 and ICAM-1 expression on 
splenic stromal cell cultures throughout development   
Splenic stromal cell cultures from E15, newborn and adult mice were treated with 
1µg/ml LTα for 24 hours, after which (a) VCAM-1 and (b) ICAM-1 expression was 
determined by flow cytometry. Purple = untreated and black = treated cells, dots 
represent individual experiments and bars represent the median (n=6). *, p<0.05 **, 
p<0.001. 
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4.2.1.1 Gene profile of LTα treated stromal cells 
As treatment with LTα affected the protein expression of VCAM-1 and ICAM-1 in 
lymphoid stromal cell cultures, the effect of LTα on gene expression was also 
assessed. TNF family members are key in mediating the LTo-LTi interaction (35), as 
well as production of cytokines such as CCL21 and CCL19 (211). Therefore a 
TaqMan low density array (LDA) was designed which contained 96 genes (appendix 
8.8) including, TNF family ligands, cytokines and chemokines to determine the effect 
of LTα treatment on stromal cells. All adult stromal cell cultures were treated for 24 
hours with 1µg/ml of LTα, after which RNA was extracted and approximately 1µg 
hybridised to the TNF LDA (appendix 8.9). Significance analysis of microarrays 
(SAM) analysis found that the expression of 21 of the genes analysed significantly 
differed between untreated and LTα treated stromal cells (appendix 8.10). 
Hierarchical clustering based on the SAM analysis grouped the LTα treated and 
untreated cells together based on their gene expression profile regardless of which 
organ the stromal cells were derived from (figure 4.4a). The only exception was 
cultures derived from the inguinal lymph node. Upon treatment the LTα treated 
stromal cells appeared to converge to a distinct genotype, principle component 
analysis (PCA) shows the tight clustering of LTα treated stromal cells (figure 4.4b), 
with downregulation of LTβ, IFN ligand family members, CCL27, CXCL27, IL-12, 
IL-23 and TNFSF8 and TNFSF15 compared to untreated stromal cells.  
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Figure 4.4 Differential gene expression between LTα treated and untreated 
stromal cells  
Total RNA from LTα treated and untreated CD45 negative sorted stromal cells was 
extracted and gene expression determined using the TNF LDA. (a) Hierarchical 
clustering of untreated and LTα treated stromal cells. Red = low, green = high and 
black = medium gene expression (b) PCA analysis based on the 21 significantly 
different expressed genes from the SAM analysis. Red circles = untreated cells and 
turquoise circles = LTα treated cells (n=6). 
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4.2.2 Leucocyte survival in co-culture with stromal cells 
Having established that the stromal cell cultures, as assessed by VCAM-1 and ICAM-
1 expression, responded to LTα in a manner indicative of LTo-like cells and coupled 
with the observation that the cultures produced of factors associated with lymphocyte 
survival, such as IL-6, IL-7 and CCL19 (section 3.2.2.5), lymphocyte survival was 
assessed in a co-culture system. Whole splenocytes were co-cultured with adult 
stromal cells derived from lymphoid and peripheral organs, conditioned medium or 
fresh medium as a control. After four days incubation, the survival of the B cells 
(CD19
+
) and T cells (CD3
+
) was determined by Annexin V using flow cytometry. 
Annexin V is a marker of cells in an early stage of apoptosis (212). Gates were used 
to eliminate apoptotic cells by including only Annexin V negative cells. A significant 
increase in the survival of B cells was observed when cultured with stromal cells from 
all organs, rather than conditioned or fresh media (figure 4.5). However, the 
percentage survival was low, generally below 10%, with little or no survival seen 
when lymphocytes were cultured with conditioned or fresh media. When T cell 
survival was assessed a significant increase was observed when cultured with all 
stromal cells, compared to conditioned or fresh media (figure 4.6). Interestingly, the 
percentage T cell survival was greater than B cell survival with the same stromal 
cells. In addition, the conditioned media was more effective at increasing T cell 
survival compared to B cells, suggesting that soluble factors present in the 
conditioned media may also play a role in T cell survival. The survival experiments 
were completed twice with three replicates in each. The two different experiments 
demonstrated variation in survival of both B and T cells, although replicates were 
tightly clustered. 
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Figure 4.5 Percentage B cell survival in co-culture with stromal cells 
One million splenocytes were added to cultured stromal cells (purple bars) or 
conditioned medium (turquoise bars) from (a) spleen, (b) thymus, (c) liver, (d) 
inguinal lymph node, (e) axillary lymph node, (f) cervical lymph node, (g) lung and 
(h) skin, with fresh medium as a control. B cell survival was determined by flow 
cytometry using Annexin V staining after four days in culture (n=6). *, p<0.05. **, 
p<0.0001. 
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Figure 4.6 Percentage T cell survival in co-culture with stromal cells 
One million splenocytes were added to cultured stromal cells (purple bars) or 
conditioned medium (turquoise bars) from (a) spleen, (b) thymus, (c) liver, (d) 
inguinal lymph node, (e) axillary lymph node, (f) cervical lymph node, (g) lung and 
(h) skin with fresh medium as a control (orange bars). T cell survival was determined 
by flow cytometry using Annexin V staining after four days in culture (n=6). *, 
p<0.05. 
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4.3 Discussion 
Gene expression profiles of all stromal cell cultures, for example LTβR, TRANCE, 
VCAM-1, ICAM-1, CCL19 and CCL21, suggested a LTo cell phenotype (chapter 3). 
These cells, in conjunction with LTi cells in vivo form secondary lymphoid tissue 
(35). An important interaction between these two cell types is the activation of LTo 
by LTα produced by the LTi cell, resulting in an increase in expression of many 
proteins including VCAM-1 and ICAM-1 (35). Therefore, the response of the stromal 
cell cultures to LTα was assessed by measuring VCAM-1 and ICAM-1 protein cell 
surface expression. A significant increase (p<0.05) in VCAM-1 expression was seen 
in all stromal cell cultures except those derived from the skin. The lack of response in 
the skin stromal cell cultures is not surprising as this is not a secondary lymphoid site 
and therefore it is reasonable to assume that it would be less likely to respond to LTα. 
Interestingly however, the lung stromal cell cultures show a significant increase even 
though it is not a secondary lymphoid site, perhaps indicating its potential for tertiary 
lymphoid formation under chronic inflammatory conditions (104). Of note, smaller 
increases in protein expression were seen in the three lymph node stromal cell 
cultures compared with cell cultures from other lymphoid sites. This may indicate a 
different phenotype within these stromal cells, which would correlate with the 
differential gene expression seen in chapter 3, where the lymph node stromal cells had 
expression of CD31 and Lyve-1, suggesting a lymphatic endothelial-like phenotype. It 
is tempting to speculate therefore that the different basal levels of VCAM-1 
expression in the stromal cell cultures represents the requirements of the specific 
stromal microenvironment at each site. Conversely, ICAM-1 expression did not 
follow the same pattern, it was significantly increased (p<0.05) only in the spleen, 
inguinal lymph node and lung stromal cell cultures, which correlates with the protein 
Chapter Four Results 130 
expression data (section 3.2.2.2). When analysing the ICAM-1 expression, stromal 
cell cultures that expressed ICAM-1 when resting could respond to LTα and increase 
expression. However, in cultures that did not express ICAM-1 in the resting cell, it 
was unable to be induced upon treatment with LTα. Previous studies have highlighted 
a variation in ICAM-1 expression in stromal cell populations from different lymphoid 
tissues, such as Peyer‟s patches and peripheral and mesenteric lymph nodes (45,198). 
It is possible that the cultured stromal cells in this study obtained from the different 
sites are representative of these different populations indicating ICAM-1 expression 
as a protein that can differentiate different stromal populations. 
 
As the LTo-LTi interaction is key in development, E15 and newborn splenic stromal 
cell cultures were also treated with LTα. The E15 stromal cell cultures expressed very 
low levels of VCAM-1 which was not upregulated upon LTα treatment, however 
ICAM-1 expression was observed and this was significantly upregulated after LTα 
treatment. Studies by White et al, 2007, found that at E15 the largest stromal cell 
population in the inguinal lymph node was ICAM-1 positive VCAM-1 negative (50), 
which correlates with the expression found in E15 splenic stromal cultures. In the 
same study it was shown that as the lymph node develops the single positive stromal 
cells mature into double positive VCAM-1/ICAM-1 expressing stromal cells by 
postnatal day 1 (50). Again these findings correlate with this study as in the newborn 
splenic stromal cell culture both VCAM-1 and ICAM-1 expression was found. The 
adult splenic stromal cell cultures show lower expression of ICAM-1 and VCAM-1 
compared with newborn splenic stromal cell cultures. This may be due to the 
maturation of the spleen in the adult mouse. However the adult spleen still upregulates 
expression of both VCAM-1 and ICAM-1 upon treatment with LTα, demonstrating 
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that the adult stromal cells still have the ability to respond when required. Scandella et 
al, 2008 demonstrated a reactivation of the LTo-LTi relationship seen in development 
after alterations in the homeostasis of adult secondary lymphoid organs (57). LTi 
cells, which are not thought to be needed to maintain non-inflammatory secondary 
lymphoid organ homeostasis, were reactivated upon destruction of the T zone stroma 
by lymphocytic choriomeningitis virus (LCMV) (57). This study provided evidence 
that the LTo-LTi interactions are still important in the adult, long after secondary 
lymphoid organ development has been completed. When analysing gene expression 
before and after LTα treatment, it was possible to group the adult stromal cell cultures 
into control and treated populations. The stromal cells seemed to converge into a 
distinct phenotype, with the treated stromal cells having a more similar gene 
expression than the untreated group. Significant downregulation of LTβ, IFN ligand 
family members, CCL27, CXCL27, IL-12, IL-23 and TNFSF8 and TNFSF15 was 
observed following SAM analysis. Most of these genes are involved in the 
inflammatory response, either by homing of T cells (CCL27) (213), differentiation of 
T cells (IL-12) (214) attracting dendritic cells and monocytes (CXCL17) (215), 
regulating lymphocyte survival (TNFSF8) (216) or promoting upregulation of 
inflammatory pathways (IL-23) (217). Downregulation of these genes is 
counterintuitive seeing as LTα is thought to be pro-inflammatory (218) and play a key 
role tertiary lymphoid formation in chronic inflammatory diseases (219). This could 
be due to the fact 1µg/ml LTα for 24 hours was not the correct dose or timing to alter 
gene expression, or it may be that LTα does not effect gene expression, only protein, 
therefore further investigations such as a luminex assay could assess 
chemokines/cytokines produced. It could also be due to the requirement for ligation of 
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other receptors on the stromal cell by mechanisms which would occur in vivo such as 
cell-cell contact between the LTo cells and the LTi cell. 
 
In addition to how the stromal cell cultures are affected by LTα, their own effect on 
lymphocyte survival was investigated. Previous work by Link et al, 2007, has shown 
an increase in survival with stromal cells via IL-7 and CCL19 (67), for which the 
cultured stromal cells have all been shown to express the genes (section 3.3.3). A 
significant increase (p<0.05) in B and T cell survival was observed, with T cell 
survival much greater when cultured with all stromal cell cultures. The difference 
seen in survival between the two separate experiments could be explained by different 
proliferation rates of the stromal cells which, in turn is dependant on where in the cell 
cycle they were when seeded. This could be addressed in future experiments by 
irradiating the stromal cells before seeding. The percentage B cell survival was 
comparable with that seen by Link et al, 2007 (67). However the percentage T cell 
survival after 4 days was lower. This highlights that the stromal cell cultures do not 
keep T cells alive as well as observed this study. It may be due to how the apoptotic 
cells were identified; in this study Annexin V staining was used by flow cytometry 
whereas in the study by Link et al, trypan blue dye exclusion was used. Annexin V 
staining by flow cytometry is a less subjective method for determining cell death as 
the number of apoptotic cells is determined by the flow cytometer using set gates and 
a large population of the cells.  
 
Previously, phenotypic differences between peripheral and lymphoid stromal cells 
were observed. In addition, within lymphoid stromal cells, the lymph node cultures 
showed differences. The aim of this chapter was to see if these phenotypic differences 
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would be mirrored in function. The response to LTα showed a definite difference 
between peripheral and lymphoid stromal cell cultures and possibly within lymphoid 
stromal cell cultures as the lymph node cultures showed a smaller increase in VCAM-
1 and ICAM-1 protein expression. Interestingly the lung stromal cells may act more 
like lymphoid tissue stromal cells when forced. All cultures increased lymphocyte 
survival indicating a general function of stroma (180). The phenotype of the stromal 
cell cultures found in chapter 3, for example LTβR, TRANCE, VCAM-1, ICAM-1, 
CCL19 and CCL21 suggested LTo-like cells. This coupled with the ability to keep T 
cells alive more successfully than B cells and gp38 gene and protein expression, 
indicates that the stromal cell cultures are comparable to a population termed 
fibroblastic reticular cells (FRCs). These are the main stromal cell population from 
the T zone of secondary lymphoid organs and have a role in the migration and 
survival of T cells within the T zone (67). 
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CHAPTER FIVE 
 
In vivo Function of Fibroblast Populations from Different Sites 
 
5.1 Introduction 
Stromal cells support the distribution, migration and survival of lymphocytes as well 
as acting as the structural backbone within lymph nodes. T zone stromal cells, termed 
fibroblastic reticular cells (FRCs); produce constitutive chemokines and support 
migrating T cells and dendritic cells (DCs). FRCs are more plentiful than other 
stromal populations within the lymph node and have been shown to express 
glycoprotein 38 (gp38 or podoplanin) (section 1.2.2.1.1) (70). They produce extra 
cellular matrix (ECM) components, which are crucial to the structural stability of the 
lymph nodes, and CCL21 and CCL19 which attract the CCR7 expressing T cells and 
DCs to the T zone. In addition, they also enhance the survival of T cells by producing 
IL-7 (71). In this study, the gene expression of the stromal cell cultures, for example 
gp38, CCL19 and CCL21, and the increase in T cell survival upon co-culture 
indicates that the stromal cell cultures are comparable to FRCs (section 1.2.2.1). To 
determine if the stromal cell cultures function as FRCs, an in vivo model was used to 
assess recruitment and organisation of leucocytes. Previous studies have shown that 
grafting embryonic lymph nodes under the kidney capsule of adult mice results in the 
formation of lymphoid tissues containing host lymphocytes which organise into B and 
T cell areas similar to the adult lymph nodes (50,220). Therefore, in this chapter, 
stromal cells alone were applied to this technique with reaggregation, host cell 
recruitment and subsequent organisation analysed. 
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In this chapter it was established that stromal cells could form reaggregates for use 
within the kidney capsule transfer model, however structural support was required for 
consistent survival in vivo. Preliminary data suggests that host leucocyte recruitment 
to the stromal cell reaggregate is possible. 
 
5.2 Results 
5.2.1 Pilot kidney capsule model studies using stromal cell reaggregates 
To ascertain if the cultured stromal cells from different sites are functionally different 
in vivo a kidney capsule transfer model was used (221). To demonstrate the success of 
this new technique whole lymphoid organs, which have been shown to work 
previously (50,222), were grafted under the kidney capsule each time initial surgeries 
were performed (figure 5.1). The survival and expansion of the embryonic and 
newborn whole organs after kidney capsule transfer confirmed the success of the 
technique. This technique was then expanded with the aim of grafting adult stromal 
cells alone, to assess the functional ability of the stromal cell cultures to recruit and 
organise host leucocytes. Firstly it was determined if a reaggregate would successfully 
form using in vitro cultured stromal cells. Reaggregates were formed from stromal 
cells using 100,000 and 150,000 cells using the V-well plate method (section 2.12). 
Reaggregates of both cell numbers could be removed from the V-well plate and 
placed in PBS whilst successfully maintaining their globular shape. This was true for 
all stromal cell lines, examples of liver, spleen and cervical stromal cell reaggregates 
are shown (figure 5.2).  
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Figure 5.1 Grafting of whole lymphoid organs under the kidney capsule  
Whole lymphoid organs dissected from newborn and embryonic C57BL6 mice were 
grafted under the kidney capsule for 1 week as positive controls (a) Postnatal day 1 
inguinal lymph nodes, (b) E15 thymus, (c) E15 spleen. Left panel shows dissected 
kidneys, right panel shows the size of the organs recovered in millimeters (n=3). 
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Figure 5.2 Stromal cell reaggregate formation  
Reaggregates were formed from 100,000 and 150,000 CD45 negative stromal cells. 
Cells were centrifuged at 900g for 5 minutes, then 225g for 5 minutes in a V-well 
plate and placed at 37°C, 5% CO2 for 24 hours. The reaggregates were removed 
placed into PBS where they maintained their structure. Pictures are representative 
reaggregates from two independent cultures.  
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Having demonstrated that the stromal cells successfully formed reaggregates, cervical 
lymph node and liver stromal cell reaggregates, formed from 100,000 cells, were 
grafted under the kidney capsule of an adult C57BL6 mouse. Stromal cells derived 
from these sites were chosen initially to compare recruitment and organisation of 
leucocytes by stromal cells from a lymph node against stromal cells from a non-
lymph node organ. When kidney capsule surgery was performed a postnatal day one 
inguinal lymph node or an E15 spleen or thymus was grafted into a separate mouse to 
ensure the technique was successful. The reaggregates were incubated for four weeks 
following grafting, a length of time used in previous kidney capsule transfer studies 
(222). After four weeks, the stromal cell reaggregate grafts had enlarged, as they were 
then clearly visible by eye (figure 5.3). The reaggregates were then dissected from the 
kidney, snap frozen and cryogenically sectioned. Immunofluorescent staining was 
performed using stromal cell markers including CD248, gp38 and VCAM-1 as well as 
markers for infiltrating host cells such as macrophage (F4/80), dendritic cells 
(CD11c), B cells (B220) and T cells (CD3). The CD45 negative stromal cells derived 
from the liver maintained their phenotype from the in vitro culture (section 3.2.2.2); 
high CD248, gp38 and VCAM-1 expression was observed in the liver stromal cell 
graft (figure 5.4). However, the staining of the stromal cell markers was not 
homogeneous and may indicate organisation of these cells within the graft. The 
positive collagen type I staining suggests that the stromal cells are functional, 
producing ECM components. The punctate PDGFRα staining indicates 
vascularisation of the graft (223). The protein expression from the liver CD45 
negative stromal cell reaggregate shows a recruitment of F4/80, CD11c, CD3 and 
small population of B220 positive cells. This suggests that host macrophages, 
dendritic cells, T cells and a small number of host B cells have been recruited into the 
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graft. Interestingly, there may be some structural organisation as there were regions 
where CD11c and CD3 positive cells clustered. Specifically, there were areas where 
CD248 was not expressed and CD3 and gp38 expression were high (figure 5.4c,d). 
This suggests a T zone area may have formed as gp38 has been shown to be expressed 
on FRC of the T zone stroma (section 1.2.2.1.1). Of note, there was a population of 
cells observed that were CD3 and CD248 positive (figure 5.4d), CD248 expression 
has been restricted to stromal cells in the previous studies (224,225), this may be due 
to the close proximity of the cell membranes of the T cell and stromal cells. Further 
staining and higher magnification images could answer this question. The protein 
expression observed from the cervical CD45 negative stromal cell graft showed 
expression of stromal markers CD248 and gp38 but this was mostly restricted to a 
capsular like structure around the edge of the graft (figure 5.5). Interestingly, VCAM-
1 expression was not seen within the graft, even though the cervical stromal cells in 
culture showed high VCAM-1 expression (section 3.2.2.2). Collagen type I 
expression again indicated that the stromal cells were functional by producing ECM 
components. Punctate PDGFRα was present indicating vascularisation of the graft. 
Recruitment of host macrophage, dendritic cells, T cells and B cells was observed but 
to a lesser extent than the liver stromal cell graft. F4/80 positive staining was 
throughout the graft where as CD11c, CD3 and B220 seemed to be restricted to the 
subcapsular area. Again B220 staining was rarely seen which concurs with the low B 
cell survival observed during in vitro co-culture with the stromal cells. The outer 
capsule which was gp38, CD248 and collagen type I positive may indicate that the 
stromal cells were attempting to form a lymph node type structure although there was 
no evidence of T and B cell compartmentalisation. Gene expression from sections of 
the recovered grafts showed expression of T cell marker CD3 and B cell marker 
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CD19 in both grafts and confirmed the recruitment of T and B cells observed by 
immunofluorescent staining (figure 5.6).  
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Figure 5.3 Grafting of CD45 negative stromal cell reaggregates under the kidney 
capsule  
Reaggregates formed from 100,000 stromal cells derived from (a) liver and (b) 
cervical lymph node were grafted under the kidney capsule for 4 weeks, after which 
the kidney was harvested and the graft dissected and snap frozen (n=1). 
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Figure 5.4 Content and structure of a grafted liver stromal cell reaggregate 
A reaggregate was formed from 100,000 CD45 negative liver stromal cells and 
grafted under the kidney capsule for four weeks. The graft was then fixed, frozen, 
sectioned and co-stained as above with cell nuclei in grey (a-d). Images taken at x40 
(n=1). 
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Figure 5.5 Content and structure of a grafted cervical stromal cell reaggregate 
A reaggregate was formed from 100,000 CD45 negative cervical stromal cells and 
grafted under the kidney capsule for four weeks. The graft was then fixed, frozen, 
sectioned and co-stained as above with cell nuclei in grey (a-d). Images taken at x40 
(n=1). 
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Figure 5.6 End point PCR from recovered kidney capsule grafts 
A reaggregate was formed from 100,000 CD45 negative stromal cells and grafted 
under the kidney capsule for four weeks. The graft was then fixed, frozen, sectioned. 
Total RNA was extracted from five 5µm sections and end point PCR performed. Cer 
= stromal cells derived from the cervical lymph node, Liv = stromal cells derived 
from the liver, +ve = positive control and –ve = negative control (n=1). 
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5.2.2 Development of the kidney capsule transfer model 
Having observed the clear survival and expansion of liver and cervical lymph node 
stromal cell reaggregates in the pilot study, the technique was then repeated with the 
remaining stromal cell cultures. As initial surgeries were completed in male and 
female mice successfully, the sex of the host mice was not thought to be an issue and 
subsequent surgeries were carried out using mostly male mice due to the ease of 
access to the kidney without the presence of ovaries. However, the successful growth 
of the other stromal cell culture reaggregates was not observed, nor could the 
successful liver and cervical lymph node stromal cell grafts be repeated, with no 
reaggregates present four weeks after grafting. To determine why the kidney capsule 
of stromal cells alone could not be repeated the quality of the reaggregate was first 
assessed. Reaggregates were made from all stromal cell cultures and instead of 
grafting under the kidney capsule were sectioned, fixed and immunofluoresently 
stained for early apoptosis marker active-caspase 3, to assess cell death within the 
reaggregates (figure 5.7). Very little or no active-caspase 3 staining was observed in 
reaggregates from all stromal cell lines. The lack of grafting success therefore, does 
not seem to be due to the increased cell death in the reaggregate. As well as active-
caspase 3, the reaggregate sections were co-stained with gp38 and VCAM-1. High 
gp38 expression was also present in all reaggregates; however VCAM-1 expression 
was not consistent. Expression of VCAM-1 was highest in spleen and inguinal lymph 
node reaggregates with little or no expression observed in the thymus, liver, skin, lung 
and axillary and cervical lymph node stromal reaggregates.  
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Figure 5.7 Structure and viability of stromal cell reaggregates  
Reaggregates formed from 100,000 stromal cells derived from the (a) spleen, (b) 
thymus, (c) liver, (d) inguinal lymph node, (e) axillary lymph node, (f) cervical lymph 
node, (g) lung and (h) skin, were snap frozen, sectioned, fixed and stained using 
immunofluorescence. Red = gp38, blue = active caspase-3, green = VCAM-1, yellow 
= co-localisation of VCAM-1 and gp38 and grey = cell nuclei. Images taken at x10, 
left panel and x40 without nuclei staining, right panel (images representative of two 
independent reaggregates). 
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Studies have suggested that expression of VCAM-1 is low under baseline conditions 
(24), which is in agreement with the expression levels seen in the reaggregates and 
cultured cells by immunofluorescence (section 3.2.2.3). VCAM-1 mediates leucocyte-
endothelial cell adhesion and signal transduction (226) and so may be important in 
attracting/retaining host cells within the graft. It has already been shown that 
treatment of the stromal cell cultures with LTα increases VCAM-1 expression in all 
stromal cell lines except the skin (section 4.2.1). Therefore, splenic stromal cell 
reaggregates were treated with LTα to determine if this would increase VCAM-1 
expression within the reaggregate and thus the success of grafting. Treatment with 
LTα showed a dose dependent increase in VCAM-1 expression in the splenic stromal 
cell reaggregate (figure 5.8). The grafted LTα treated CD45 negative splenic stromal 
cells have maintained their phenotype from the in vitro culture (section 3.2.2.2); high 
CD248 and gp38 expression was observed (figure 5.9). Very low PDGFRα staining 
was seen indicating little or no vascularisation of the graft. The protein expression of 
F4/80, CD11c, CD3 and small population of B220 positive cells, suggests recruitment 
of host macrophages, dendritic cells, T cells and a small number of host B cells. The 
protein expression within the graft was similar to that seen in the untreated stromal 
cell grafts in terms of recruitment of host cells (section 5.2.1) conversely, no outer 
capsule formation or T zone organisation was seen. However, as with the grafting of 
untreated stromal cell reaggreagtes, this could not be repeated successfully when 
grafts of all other LTα-treated stromal cell cultures were attempted and no 
reaggregates were present seven days after grafting.  
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Figure 5.8 Lymphotoxin α treated splenic stromal cell reaggregates  
Reaggreagtes formed from 100,000 splenic stromal cells were treated with LTα for 24 
hours, (a) untreated, (b) 1µg/ml and (c) 2µg/ml, after which they were snap frozen, 
sectioned, fixed and stained using immunofluorescence. Red = gp38, blue = caspase-
3, green = VCAM-1, yellow = co-localisation of VCAM-1 and gp38 and grey = cell 
nuclei. Images taken at x40 (images representative of two independent reaggregates). 
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Figure 5.9 Seven day grafted, LTα treated splenic stromal cell reaggregate 
A reaggregate formed from 100,000 CD45 negative splenic stromal cells was treated 
with 1µg/ml LTα for 24 hours and grafted under the kidney capsule for seven days. 
The graft was then snap frozen, sectioned, fixed and co-stained as above (a-d) with 
cell nuclei in grey. Images taken at x40 (n=1). 
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5.2.3 Kidney capsule transfer using gelatine sponge supported stromal cells 
Having observed that stromal cells alone and LTα treated stromal cells had failed to 
give consistent results in kidney capsule transfer, addition of physical support was 
tried. Seemayer et al, 2003 and Suematsu et al, 2004 have previously reported 
successful use of a 3D-sponge to provide structure for stromal cells within kidney 
capsule surgery (69,227). Therefore, the in vitro cultured splenic stromal cells were 
suspended in a gelatine sponge, instead of forming a reaggregate, prior to surgery. 
Kidney capsule transfer was then completed using stromal cells present within a 
collagen sponge. Encouragingly, after 7 and 14 days the sponges remained present 
under the kidney capsule, although they did not appear to have increased in size. The 
grafts were removed, cryosectioned, fixed and stained using immunofluorescence for 
donor stromal cell marker expression, such as gp38 and CD248, and infiltrating host 
cells, such as macrophage (F4/80), dendritic cells (CD11c), B cells (B220) and T cells 
(CD3). The morphology observed after grafting for 7 days was different to that of the 
stromal cells alone, spaces could be seen without cells, presumably where the sponge 
was present (figure 5.10). However cells were retained in the sponge and expression 
of gp38 and CD248 were high confirming stromal cell presence. There was also 
evidence of recruitment of host cells, with CD11c and F4/80 expression found. 
However in contrast to the pilot and LTα treated grafts, no CD3 or B220 positive 
staining was observed, suggesting that no T or B cell recruitment had occurred. 
Although this was on day seven, therefore it may occur at a later time point as the 
pilot grafts were at week four. The protein expression seen after 7 days was the 
comparable with that after 14 days under the kidney capsule, with an increase in 
F4/80 expression observed, indicating further macrophage recruitment (figure 5.11). 
Using the collagen sponge as structure for the stromal cells under the kidney capsule 
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provided more consistent results with successful repeats of both seven and fourteen 
day grafts. 
Chapter Five Results 157 
 
Chapter Five Results 158 
 
 
 
Figure 5.10 Seven day grafted, splenic stromal cells suspended in a gelatine 
sponge  
A gelatine sponge (2-3mm
3
) was placed in 50µl complete fibroblast media with 
100,000 CD45 negative splenic stromal cells for 2 hours prior to surgery, after which 
it was grafted under the kidney capsule for seven days. The graft was then fixed, 
frozen, sectioned and co-stained as above (a-d) with cell nuclei in grey. Images taken 
at x40 (n=2). 
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Figure 5.11 Fourteen day grafted, splenic stromal cells suspended in a gelatine 
sponge 
A gelatine sponge (2-3mm
3
) was placed in 50µl complete fibroblast media with 
100,000 CD45 negative splenic stromal cells for 2 hours prior to surgery, after which 
it was grafted under the kidney capsule for fourteen days. The graft was then fixed, 
frozen, sectioned and co-stained as above (a-d) with cell nuclei in grey. Images taken 
at x40 (n=2). 
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5.3 Discussion 
Gene and protein data suggested that not only are adult CD45 negative stromal cells 
cultured from peripheral and lymphoid organs different but also that lymph node 
cultures had different profiles when compared to other lymphoid organs tested 
(chapter 3). These differences were also upheld when in vitro functional studies were 
performed (chapter 4). Moreover, these data highlighted that the stromal cell cultures 
maybe similar to the FRCs due to their ability to differentially keep CD3 positive cells 
alive (section 4.2.2). Therefore, the kidney capsule transfer model was utilised to 
examine whether these stromal cells, in vivo, were able to survive, organise and 
recruit host leucocytes, differentially depending on these differences observed. 
 
An initial pilot study demonstrated that it was possible to form reaggregates from the 
CD45 negative stromal cells using the V-well plate method, which grew successfully 
when grafted under the kidney capsule. This study suggested that these grafts were 
able to recruit host dendritic cells, macrophages, T and B cells into the reaggregate. It 
was also indicated that there may be differences between the stromal cells used with 
the liver stromal cell reaggregate organising the T cells into areas where there was 
low expression of CD248 or collagen type I. Interestingly, these T cell areas had a 
high expression of gp38, which is thought to be expressed on T zone stromal cells 
(72). In contrast, the cervical stromal cell graft was quite different; there was little 
evidence of any host cell organisation but CD248,
 
gp38 and collagen type I 
expressing stromal cells formed a capsule-like structure around the edges of the graft. 
Protein expression within the capsule agrees with that seen previously by Lax et al 
(2007) where CD248 expression was observed in the lymph node caspsule (140) and 
also by Katakai et al (2004) where gp38 expression was seen the lymph node capsule 
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(71). However, the data could not be repeated nor was it successful with the 
remaining stromal cell lines. Therefore, the quality of the stromal cell reaggregates 
was assessed by active-caspase 3 expression, which confirmed that the reaggregates 
did not contain many apoptotic cells. To further ensure the quality of the grafts, the 
quantity of necrotic cells could also be assessed using haematoxylin and eosin 
staining. VCAM-1 expression in these reaggregates was low and as VCAM-1 is 
thought to be important in the interaction between stromal cells and lymphocytes 
(226), it was reasoned that increasing VCAM-1 expression could make a more 
successful reaggregate. LTα treatment has been shown to increase VCAM-1 
expression in cultured stromal cells, therefore the reaggreagates were treated with 
LTα (1µg/ml) for 24 hours. The preliminary LTα treated splenic stromal cell 
reaggregate was successful and after seven days had recruited host macrophage, 
dendritic cells, T and B cells, although less stromal organisation was appreciated 
compared to the pilot grafts. However, when repeated again, as with untreated LTα 
stromal cells, the grafts were unsuccessful. A technique used by Seemayer et al 
(2003) is to use a 3D-sponge as structure for the implanted cells (227). Cells are 
trypsinised and added onto the sponge, which is then co-implanted with pieces of 
human cartilage under the renal capsule of SCID mice to analyse the invasion of the 
cartilage by fibroblasts. Therefore, this technique was adopted for use with the 
stromal cells. Importantly, the kidney capsule grafting using the gelatine sponge 
structural support were successful with grafts analysed after seven and fourteen days 
post implantation. The data from these grafts showed consistent growth and survival, 
with expression of stromal cell markers CD248 and gp38 but not VCAM-1. Host 
macrophage and dendritic cells but no T or B cells were recruited unlike unsupported 
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grafts. T and B cell entry may occur after fourteen days as the pilot grafts were 
incubated for four weeks. 
 
In conclusion, data in this chapter provides a method for analysing the function of 
cultured stromal cells in vivo. This involves using a gelatine sponge as structural 
support for the implanted stromal cells. Using this technique, adult splenic stromal 
cells for the first time have been shown to form a structure which is able to recruit and 
support host CD11c and F4/80 positive leucocytes. It will be interesting in the future 
to repeat with all cultured stromal cells and look for possible differences between 
peripheral and lymphoid sites in the recruitment of leucocytes. 
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CHAPTER SIX 
General Discussion 
 
Stroma is an important structural component of vertebrate animals. It consists of 
extracellular matrix (ECM), mesenchymal cells and a scaffold consisting of nerves 
and blood and lymphatic vessels (119). The most abundant cell type of tissue stroma 
is the fibroblast (120). In recent years it has become clear that fibroblasts play not 
only an active role in defining the structure of tissue microenvironments but also 
modulating immune cell behaviour by conditioning the local cellular content and 
cytokine production, specifically tailoring the response to the cause of the damage 
(113). Fibroblast gene expression in humans has been studied by many groups 
(119,136,150,151,228). It has become apparent that there is considerable positional 
memory and topographic differentiation as defined by their gene expression profiles. 
Interestingly, a set of 337 human fibroblast genes has been found which varies 
according to three anatomical divisions: anterior-posterior, proximal-distal and 
dermal-nondermal. These genes were involved in pattern formation, cell-cell 
signalling and matrix remodelling (151). It is therefore reasonable to hypothesise that 
this may also be the case among mouse fibroblasts, in particular for this study within 
the murine lymphoid organs. In addition, given the degree of homology between 
many human and murine genes, it could be possible that the site defining genes found 
in the human are also important in the mouse.  
 
In this thesis, stromal cells from different lymphoid and peripheral sites were cultured 
and characterised in terms of morphology, protein expression and gene expression to 
define site specific profiles within the populations. In addition, following phenotypic 
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and genotypic analysis functional differences between the cultured stromal cells were 
investigated. These analyses confirmed the diversity of morphology, gene and protein 
expression between the cultured stromal cells. Furthermore, preliminary functional 
assays also confirm that fibroblasts from different sites differ in their ability to not 
only to respond to lymphotoxin α (LTα) in vitro, but also form tissue reaggregates and 
recruit host leucocytes in vivo. 
 
6.1 Fibroblast reticular cell phenotype 
In this study a method of successfully culturing stromal cells and sorting these into a 
homogenous fibroblast population based on CD45 protein expression was developed. 
Fibroblast populations were defined by their ability to adhere to plastic, expression 
cell surface proteins (CD248, VCAM-1 and gp38) and gene expression (CCL19, 
CCL21, CD248, VCAM-1, ICAM-1, gp38, CXCL12 and LTβR) with a lack of 
expression of other cell lineage markers. Previous studies have described a stromal 
cell type called a fibroblast reticular cell (FRC) from the T zones of lymph nodes. 
These cells highly express gp38, PDGFRα, LTβR and VCAM-1 amongst others and 
were also found to be a major source of IL-7 (67,71). This phenotype is very similar 
to the cultured stromal cells described in chapter three. Importantly a consistent 
finding was that the lymph node stromal cells had differential gene expression of 
CD31 and Lyve-1 when compared to the stromal cells from other sites, which may 
suggest a lymphatic endothelial population from the lymph nodes. In addition to the 
FRC cell type, a gp38, CD31, Lyve-1, VCAM-1 and LTβR positive population was 
also described (67), termed lymphatic endothelial cells (LECs), which closely 
matches that seen in the lymph node stromal cell populations. Therefore, these data 
indicate that two different populations are being isolated from the different sites using 
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the same method. More recently, a stromal cell population, termed marginal reticular 
cells (MRCs) was found in the outer follicular region immediately underneath the 
subcapsular sinus of lymph nodes in adult mice. These cells expressed VCAM-1, 
ICAM-1, MadCAM-1, CXCL13, TRANCE, BP-3 and gp38 and have been described 
as specialised reticular fibroblasts (69). The stromal cells in this study express little or 
no CXCL13 but given the similarity in gene expression to the MRCs, it is possible 
that they are present in the stromal cell cultures. In chapter four, in vitro functional 
studies showed that all cultured stromal cells increased the survival of T cells more so 
than B cells in a co-culture system. Preliminary results from the in vivo kidney 
caspsule transfer pilot studies in chapter five also showed a preferential recruitment of 
T cells to B cells into the stromal cell grafts. Taken together, these data indicate that 
the cultured lymphoid stromal cells in this study are comparable to FRCs. As FRCs 
are found in the T zones of secondary lymphoid organs, the FRC-like cells derived 
from non-lymphoid sites may have the potential to form tertiary lymphoid structures 
should the correct conditions arise, for example chronic inflammation. 
 
6.2 Fibroblast heterogeneity exists between murine lymphoid organs 
Primary adult human fibroblasts have been shown to retain many features of the 
embryonic pattern of the expression of HOX genes (119,151). It is thought that the 
expression of these genes may dictate positional identity. The stability of HOX gene 
expression was shown over 35 passages by Rinn et al in 2008. Gene expression 
patterns were assessed by culturing fibroblasts from one site in conditioned media 
from another and also culturing two sets of fibroblasts from different sites together. 
Neither of these altered the gene expression significantly and the fibroblasts were still 
able to be clustered site specifically based on their gene expression. However it was 
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reported that gene expression of cultured fibroblasts can be altered by treatment with a 
histone deacetylase inhibitor. These results are consistent with earlier findings that 
site specific HOX expression is epigenetically maintained by chromatin modifications 
in fibroblasts (152,229). Stability was also observed in the cultured murine stromal 
cell cultures in this study with regard to their protein and gene expression over many 
passages. A gene signature from CD45 negative stromal cells was determined using 
whole genome microarrays, which was able to differentiate lymphoid tissue stromal 
cells from peripheral tissue stromal cells. However, this could not differentiate 
between stromal cells from different lymphoid tissues. Further studies using low 
density arrays (LDAs) containing genes found to be important in grouping human 
fibroblasts indicated that Hoxd8, Grem2, Cdh1 and Mmp3 may differentiate between 
lymphoid tissue derived stromal cells, although protein expression has yet to be 
determined and requires further investigation. Functional data from in vitro LTα 
treatment in chapter four confirmed a definite difference between peripheral and 
lymphoid stromal cell cultures, where LTα was able to induce a significant increase in 
VCAM-1 protein expression in all stromal cell cultures but not in those derived from 
the skin. Differences were also seen within lymphoid stromal cell cultures as the 
lymph node cultures showed lesser response to LTα treatment in comparison to other 
sites. Pilot in vivo kidney capsule studies in chapter five demonstrated a difference in 
organisation of donor stromal cells and host recruited leucocytes between liver and 
cervical lymph node derived stromal cell grafts. These data illustrate that differences 
observed in gene and protein expression may also be relevant when considering 
function of stromal cells derived from different sites. 
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Previous work by this group has suggested a stromal area postcode regulates 
leucocyte survival, retention, proliferation and differentiation within lymphoid tissues. 
This thesis supports this hypothesis, with peripheral tissues, lymphoid tissues and 
lymph node stromal cells having distinct phenotypes and preliminary functional data 
showing differences in their response to LTα and in the recruitment and survival of 
leucocytes. Many inflammatory diseases have site specific manifestations, for 
example rheumatoid arthritis mainly in the synovium and psoriasis in the skin. 
Inappropriate expression of all or parts of the code may therefore play a key role in 
the instigation or continuance of disease and make stromal cells a therapeutic target. 
Specific medication targeting „activation markers‟ of stromal cells could alter the 
phenotype of the cell to a more „resting state‟, thereby modifying the function of the 
stromal cells as an anti-inflammatory therapy.  
 
6.3 Future work leading from this study 
The investigations within this thesis have examined the hypothesis of a stromal area 
postcode within murine lymphoid tissues. The genes found to be differentially 
expressed by the TNF LDA between the stromal cell cultures from different sites, 
require further investigation, such as completion of protein expression of these genes 
to confirm they are differentially expressed. Should these genes be able to 
differentiate between stromal cells from different sites it would be interesting to 
manipulate the genes involved. For example using a gene knock-in to induce 
expression or RNA interference to silence the gene, to analyse whether one particular 
stromal cell then becomes more phenotypically like another. To assess functionality, 
cultured stromal cells from different sites of eYFP expressing mice could be 
adoptively transferred to determine if they traffic back to their organ of origin, this 
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would be a key experiment to answer the question of the stability of regional identity. 
Combining these two experiments and altering the gene expression of the stromal 
cells before adoptive transfer would show whether it is possible to then change 
stromal cell function by modifying its phenotype and analysing the trafficking of that 
altered stromal cell. 
 
The in vitro cultured stromal cell genotype was more similar to an immortalised 
stromal cell than an ex vivo sorted stromal cell, suggesting that in vitro culture affects 
the stromal cell gene expression. Although ex vivo stromal cell numbers are low, it 
would be interesting to sort stromal cells from different sites and compare their gene 
expression. Resting and inflamed tissue could also be compared to determine if 
regional identity is maintained in an inflammatory response. 
 
The kidney capsule transfer model using the structural support of the gelatine sponge 
can be used to analyse in vivo recruitment and survival of host leucocytes from 
splenic stromal cell cultures. This model can now be used as an in vivo functional 
readout for the role of stromal cells and other cell types in the formation of lymphoid-
like structures. Kidney capsule transfers for all stromal cell cultures should be 
completed to confirm the technique and look for differences in recruitment and 
survival of leucocytes. eYFP mice should next be used to confirm that the stromal 
cells found in the recovered grafts are from the donor cell cultures and the leucocytes 
found are host derived, as there is the possibility of host stromal cell invasion. This 
model could then be expanded, by creating reaggregates for grafting of stromal cells 
from different sites with lymphoid tissue inducer (LTi) cells from the same or other 
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sites to see if these can recruit leucocytes and organise them into classical T and B 
cell compartments. 
 
Taken together these data emphasise the phenotypic and functional differences of 
stromal cells derived from peripheral tissues, lymphoid tissues and lymph nodes and 
consolidate stromal cells as more than just a structural component within organs.
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